Exam 4 is the pulmonary block plus point-of-care ultrasound and transfusion medicine. The course rules below come from Professor Reynolds’ first lecture and hold for every exam in this class; the last rows are what they mean for each lecture.
| The rule | What it means for you |
|---|---|
| “I’m not going to just throw a random number at you and not give you context of whether that’s high or low.” (Professor Reynolds, Lecture 1) | Reference ranges are supplied. A creatinine or any other value in a stem comes with the range that reads it. Learn what a value means. |
| “It’s going to likely be more related to the tests themselves rather than maybe the specific diagnosis.” (Lecture 1) | Which study, why, its cautions and what normal looks like on it carry most of the marks (17.7). |
| Questions are vignette and next-best-test: “what would be the next test that you would order?” | In imaging the next test is a study: the radiograph first; the angiogram first for a suspected pulmonary embolism; computed tomography when the radiograph is inconclusive; the ventilation/perfusion scan when contrast cannot be given (17.7). |
| Images are in play: radiographs and scans alongside the vignette. | Expect a film or a slice. Read the technique first (17.6), then the structures (17.1–17.5), then the pattern (17.8). |
| Blood gases: every pH, gas pressure, bicarbonate and electrolyte in a stem comes with its normal range. The anion gap is the one calculation: “I do want you to memorize and understand this equation” (Professor Finck, Lecture 19). | Read the gas step by step: the pH, then the values outside their range (the carbon dioxide for the lungs, the bicarbonate for the metabolic side), then whether the labs fit the patient (19.5). Know the four patterns and their compensation (19.5, 19.6). Work out the gap as sodium minus (chloride plus bicarbonate), with no potassium (19.7). |
| Pulmonary function tests: a value comes with its reference (percent of predicted, or the report’s own reference column). | Read a report in order: the ratio first, then the forced vital capacity, then the total lung capacity (18.6). Expect a tracing, a loop or a report: know the normal shapes and the scoop and the witch’s hat (18.5). The next test: spirometry for obstruction, lung volumes for restriction, the diffusing capacity for a gas transfer problem (18.7). |
| Point-of-care ultrasound: pictures are in play (a scan, a window, an artifact), and the bedside scan is a complement to the history and physical, not a replacement. | Know the probes (linear high frequency and superficial, curvilinear low frequency and deep), the echogenicity words, the artifacts (shadowing, enhancement, edge, mirror, A and B lines), the four cardiac windows with the subxiphoid for an effusion, lung sliding and the lung point, inferior vena cava collapse over 50%, compressibility for a clot, cobblestoning, and the EFAST windows (20.2–20.9). When the patient is stable, formal imaging is often still the answer (20.10). |
| Transfusion medicine: every lab value in a stem comes with its range; “this is not pathophys, this is diagnostics” (Professor Reynolds, Lecture 21). | Read the tests: forward and reverse typing must mirror each other, a positive screen means an identification panel and a full antiglobulin crossmatch, and the direct antiglobulin test sorts the reactions (newly positive in the acute and delayed hemolytic reactions). For any suspected reaction, stop the blood first (21.8–21.19). |
17 · Pulmonary Imaging
Professor Fowler, guest lecturer · 20 October 2026
Instructional Objectives
Topic Outline 17: Pulmonary Imaging
- Identify normal pulmonary structures on radiographic imaging.
- Identify normal bony thoracic structures on chest radiographs.
- Identify abnormal chest imaging findings.
- Compare and contrast imaging modalities used in pulmonary disease.
- Recognize common imaging findings associated with: i. Pneumonia · ii. Pleural effusion · iii. Pulmonary edema · iv. Pneumothorax · v. Interstitial lung disease
The one-line frame for the whole lecture. Know what normal looks like first (the landmarks you can feel, the structures on the film and on the scan), so that an abnormal film jumps out. Before calling anything disease, check the technique (exposure, inspiration, rotation, which view). Then match the question to the study: the chest radiograph comes first for almost everything, the computed tomography angiogram comes first for a suspected pulmonary embolism, and every other modality has its own niche and its own cautions. Finally, recognize the five patterns: pneumonia, pleural effusion, pulmonary edema, pneumothorax and interstitial lung disease.
Light and dark: air lets the beam through, so it is radiolucent (dark) on a radiograph and low attenuation (dark) on computed tomography; bone stops it, so it is radiopaque (white) and high attenuation (bright). Almost every question in this lecture comes back to that.
| In the recording | So |
|---|---|
| “The nipple line corresponds, this is important. The nipple line corresponds to the fifth intercostal space.” Then the sternal angle and the second rib. [segment 1, 4:53–5:16] | Two landmarks to know cold (17.5): sternal angle = second rib; nipple line = fifth intercostal space. |
| On the lateral soft-tissue neck film: “This is a very important image to kind of get in your head … it’s the trachea. That’s important. It’s full of air.” [segment 1, 15:08–15:41] | The dark air column is the trachea; the airless esophagus behind it is normal (17.3). |
| “You also want to pay attention to the curvature of the cervical spine. There should be a slight anterior curve.” [segment 1, 10:59–11:11] | Normal cervical lordosis on the lateral neck film (17.3, 17.5). |
| The anteroposterior and posteroanterior views: “These are the views, these are important. Get to know what this means.” And “if you looked at this, you might go, ooh, that’s a big heart. But if you know the position in which it was taken, you’re gonna filter that differently.” [segment 1, 20:52 and 22:12] | The supine anteroposterior film magnifies the heart (17.1, 17.6). |
| “There’s a thing called the one-third two-thirds rule … one third of the heart is on the right side, and two-thirds of the heart is on the left side.” [segment 1, 24:55–25:07] | 17.2, with the half-the-chest limit for heart size. |
| The costophrenic angle: “that’s important. That’s an important structure to get to understand what looks normal”; “nice and sharp, very important.” [segment 1, 26:46 and 40:19] | Sharp is normal; blunted is a pleural effusion (17.1, 17.8). |
| The aortic knob: “This is an important structure on X-ray … Remember that. The aortic knob.” [segment 1, 36:19–36:25 and 39:09] | 17.1. |
| Rotation: “you don’t use the trachea as that defining point … the trachea is a tube … if you’re rotated, it’s going to look the same.” [segment 1, 30:36–30:47] | Measure from the spinous processes to the clavicle borders (17.6). |
| “Remember, very important point, trachea should be in the midline.” [segment 1, 35:35] | 17.2 and 17.6. |
| “It’s important to remember that the left hilum is higher on imaging.” [segment 1, 39:36] | 17.2. A left hilum slightly above the right is normal. |
| “Always, always, always, you gotta check pregnancy test for any childbearing age female. Always.” [segment 1, 43:33] | 17.7: a beta human chorionic gonadotropin test before imaging. |
| “Imaging modalities have very few true contraindications. Very important to remember.” Then “Anaphylactic reaction to shellfish, this is important.” [segment 2, 12:39–13:18] | 17.7: pregnancy is a caution, not an absolute block; the shellfish line is a contrast caution. |
| The ventilation/perfusion scan: “It is inferior to a CT angiogram. Remember that.” And the tracer: “Worthless information for a party. But you need to know that’s the material.” [segment 2, 27:58 and 28:22] | 17.7. |
| “Gotta know the Kerley B lines.” [segment 2, 45:01] | Short horizontal lines from thickened interlobular septa (17.8). |
| Interstitial lung disease: “A pulmonologist will be telling you what they see, but you need to be able to recognize that don’t look right.” [segment 2, 48:48] | Recognize the abnormal pattern; the vocabulary helps you read the report (17.8). |
Said to be beyond what you need: the order a radiologist reads a scan in (“Are you gonna get that deep into this? No.”, segment 2, 6:44; but “if somebody showed you a sagittal CT, you need to be able to go, oh, that’s a sagittal CT”); reading a ventilation/perfusion scan yourself (“Are you going to be reading that? No.”, 28:56); the kinds of pneumonia on a film (“I don’t want you to get into the minutia,” 39:30); the details of magnetic resonance weighting (“we’re not going to dwell a lot of time on it,” 31:58). Vasculograms are “very difficult to read … left to the radiologist”, but the major vessels and the orientation pearls are fair game. The quizzes follow these lines.
Where the time went (distinct minutes of speech, about 97 in all; both transcripts): the modalities (objective d) about 36 minutes, the normal structures and the upper airway films (objective a) about 31, the bony and surface landmarks (b) about 9, technique and the abnormal checklist (c) about 8, and the five patterns (e) about 10. The quizzes are weighted the same way, with one question per pattern in each set because the syllabus names all five.
Where the slide and the recording differ. (1) Larynx: the slide says C3 to C6; the recording says “C3 and C9” twice (segment 1, 3:48 and 4:01). There is no C9 (seven cervical vertebrae); the slide is keyed. (2) Ultrasound was described as “radio waves” (segment 1, 45:15). Ultrasound uses high-frequency sound waves; the point that holds is that it is not ionizing radiation. Not asked. (3) The pleura was described as a “visceral” and a “parenchymal” layer with the inner one nearest the lung tissue called parenchymal (segment 1, 47:00; segment 2, 41:42). The standard names are the visceral pleura (on the lung) and the parietal pleura (lining the chest wall), which is how slide 9 labels it. Not asked. (4) The heart looking bigger on the anteroposterior film was put down to gravity in the recording; the slide says only “heart magnified”, and only that is asked. (5) Pacemakers: the recording said most are now made of materials safe for magnetic resonance; the slide lists “metallic implantable devices that are not titanium” as the precaution, and no question asks about pacemakers in the scanner. (6) Coagulated blood is listed as low attenuation on slide 49 and normal to low on slide 51; not asked. (7) Slide 39’s note calls its lateral film overexposed while slide 29 defines overexposure as dark; not asked.
17.1 · Objective a — The chest radiograph: when, which view, and the normal film
Chest radiographs are the most common radiologic study: radiographs account for 75% of all radiology images ordered in the United States, and the chest radiograph is almost always the first-line study for a pulmonary or cardiac complaint. Pain and shortness of breath are the primary chief complaints associated with it.

The two frontal views
| View | Patient | What it does to the film |
|---|---|---|
| Posteroanterior (beam enters from behind) | Ambulatory: standing, chest against the plate | The standard film; heart size can be judged. |
| Anteroposterior (beam enters from the front) | Supine: in bed, often a portable film | ★ The heart is magnified, so a big-looking heart on an anteroposterior film is not, by itself, an enlarged heart. |

The normal structures on the frontal film
Images are always viewed as if you are facing the patient: the patient’s left is on your right, which is why the heart points to the right of the screen. Find each of these on every film:
- Trachea: a dark (radiolucent) air column in the midline with a smooth border; it divides at the carina into the main bronchi.
- ★ Aortic knob (the aortic arch): the rounded bulge at the top of the left mediastinal border. Just below it is the pulmonary artery (pulmonary trunk), then the left hilum.
- Heart borders: the right atrium forms the right heart border; the left ventricle forms the lower left border down to the diaphragm.
- Hila (17.2), the pulmonary markings fanning out from them, and the superior and inferior vena cava on the right.
- Hemidiaphragms: the two domes; the liver sits under the right one and the gastric bubble (gas in the stomach) under the left.
- ★ Costophrenic angles: the sharp V where each hemidiaphragm meets the lateral chest wall. Nice and sharp is normal; blunting is the sign of a pleural effusion (17.8). The cardiophrenic angle is the medial corner where the heart border meets the diaphragm.



17.2 · Objective a — Reading the film: the systematic scan, heart size, the hila and the lateral view
The read is the same every time:
- Scan the lung fields: they should be radiolucent because they are filled with air. Trace the margin of each lung, then sweep across each part of it, comparing left with right for symmetry.
- Assess the retrosternal space and the retrocardiac space (best seen on the lateral film).
- ★ Heart size: the heart should be no more than half of the posteroanterior span of the chest. The one-third, two-thirds rule: about one third of the heart lies right of the midline, two thirds to the left.
- Vascular markings: the pulmonary arteries and veins should be the only real vascular markings you can see.
- Ribs: assess each rib one at a time, on both sides, before moving down to the next one.
- Axial skeleton: the bony alignment; the spinous processes should be midline.
- Trachea and primary bronchi: a smooth radiopaque border with a radiolucent interior, and ★ the trachea should be midline.


The hila
- Each hilum bisects the chest: equal lung above and below it.
- It is mostly the pulmonary arteries and veins, with some fat, lymph nodes and bronchial walls.
- ★ The left hilum is slightly higher than the right: a normal finding.
- The shape is concave, and the two should be similar in size and density.

The lateral film
The lateral view shows the retrosternal space (behind the sternum, in front of the heart) and the retrocardiac space (behind the heart), the trachea, the aortic arch, the pulmonary artery, the right ventricle (front) and the left ventricle (back). The normal thoracic spine has a posterior arch, with disc spaces present and symmetric.


17.3 · Objective a — The upper airway films: skull, sinuses and the soft-tissue neck
How to read a skull or soft-tissue neck radiograph: move superior to inferior, sweeping your eyes left to right, then down a little and left to right again, comparing. Note that the airways are radiolucent (dark); note the air-filled sinus cavities; check the bones for continuity; ★ make sure there is a slight anterior curve of the cervical spine (normal cervical lordosis); assess the soft tissue of the peripharyngeal structures; and always assess for symmetry.
Indications for a facial, skull or soft-tissue neck radiograph: a muffled voice; stridor (wheezing heard through the patient’s mouth without a stethoscope); suspected sinus infection (the Water’s view, which is not really needed but can help confirm it and possibly reduce antibiotic use); and anterior neck pain.


★ The lateral soft-tissue neck film (“a very important image to get in your head”):
| Letter | Structure | Letter | Structure |
|---|---|---|---|
| A | Nasopharyngeal space | F | Hyoid bone |
| B | Retropharyngeal space | G | Vocal cords |
| C | Retrotracheal space, also where the esophagus is | H | C7: the next vertebral body is partly obscured by the first rib |
| D | Epiglottis | I | Trachea |
| E | Vallecula |
- The trachea is patent and radiolucent (dark, because it holds air).
- The esophagus shows no radiolucency: it is collapsed, which is what it should be when the patient is not eating. No air in it is normal.
- Note the slight anterior curve of the cervical spine.


17.4 · Objective a — Normal structures on computed tomography and the angiogram
A computed tomography image is a slice, not a shadow of everything stacked together like a radiograph. Know the three planes on sight: transverse (axial), a cross-section; frontal (coronal), both lungs side by side from apex to base; and sagittal, one side in profile, front to back. The lung window shows the lung tissue in high detail; in it the trachea and bronchi are dark circles because they are full of air.

Why the trachea and bronchi are dark on computed tomography. Air and gas are low attenuation, so the air-filled trachea and bronchi show dark on computed tomography.

Pulmonary vasculograms are almost exclusively computed tomography angiograms. They are very difficult to read and best left to the radiologist, but find the major vessels. Pearls of the trade:
- Lost your orientation in the confusing-looking heart? Find the descending aorta: it is always on the left side of the patient’s vertebral column, a bright round vessel beside the spine.
- In the transverse view the patient’s left is always your right, and vice versa.
- The heart is more on the patient’s left. The right ventricle is closest to the sternal wall; the left ventricle always has the thickest wall.
- When assessing for an embolism or thrombus, the pulmonary arteries are of greatest concern.






17.5 · Objective b — Bony thoracic structures and the surface landmarks
| Landmark | What it tells you |
|---|---|
| ★ Sternal angle (manubriosternal joint) | Communicates with the second rib: how you find the second rib for procedures, and where you start to palpate and count the ribs down. |
| ★ Nipple line | Corresponds to the fifth intercostal space. |
| Fifth rib | Below (inferior to) the base of the fifth rib are the inferior lobes; above (superior to) it are the superior lobes. |
| Jugular notch | Deep to it is the trachea. |
| Larynx | From C3 to C6; about 1 centimeter inferior to the laryngeal prominence is the cricothyroid ligament. |
| Lesser supraclavicular fossa | Deep to it are the internal jugular vein and the common carotid artery (“internal common carotid” on the slide). |
| Posterior triangle of the neck | Contains the subclavian vein and the lung apices. |
| Carotid triangle (part of the anterior triangle) | Contains the bifurcation of the common carotid artery. |
| Sternocleidomastoid | Divides the anterior triangle from the posterior triangle; the trapezius forms the posterior triangle’s back edge. |
| Glabella and the zygomatic process of the maxilla | Deep to the glabella are the frontal sinuses; deep to the zygomatic process, the maxillary sinus. |


The bones on the films
- Ribs: assessed one at a time, both sides, then the next one down; anterior and posterior ribs can both be numbered on the frontal film. The checklist for bones is lesions or fractures, and always assess for symmetry.
- Spine: the spinous processes should be midline. On the lateral chest film the normal thoracic spine has a posterior arch with disc spaces present and symmetric. On the lateral neck film the cervical spine has a slight anterior curve (lordosis), and the vertebral body below C7 is partly hidden by the first rib.
- Clavicles and scapulae lie over the upper chest on the frontal film; the clavicle borders are what rotation is measured against (17.6).
- If a radiograph is inconclusive for a rib or spinal fracture, computed tomography is the best imaging modality for bone (17.7).

17.6 · Objective c — Abnormal findings: is it the film or the patient?
Before calling a film abnormal, check the technique. Each of these makes a normal chest look abnormal:
| Check | Adequate | When it is off |
|---|---|---|
| Exposure | Vessels seen to at least the peripheral third of the lung; the paraspinous margins and the left hemidiaphragm behind the heart visible. | Overexposure: dark; the thoracic spine, mediastinal structures, retrocardiac areas and the nasogastric and endotracheal tubes show through. Underexposure: white; small pulmonary vessels, no spine and no mediastinal anatomy. |
| Inspiration | A deep breath brings the domes of the hemidiaphragms down to the tenth posterior rib standing (eighth to tenth seated or lying). | Poor effort leaves the diaphragm high over only a few posterior ribs and hides lung. |
| Rotation | Measured from the center spinous processes to the borders of the clavicles: equal on both sides. | Uneven distances. ★ Do NOT use the tracheal shadow: the trachea is a tube and looks the same when rotated. |
| View | Posteroanterior, standing. | Supine anteroposterior: the heart is magnified, so do not call it enlarged on that view alone. |




What each structure is checked for
| Structure | Abnormal finding to look for |
|---|---|
| Trachea | Midline or deviated, caliber, mass. A deviated trachea is abnormal. |
| Lungs | Abnormal shadowing or lucency |
| Pulmonary vessels | Artery or vein enlargement |
| Hila | Masses, lymphadenopathy |
| Heart | Width against the thorax (no more than half the chest), cardiac configuration |
| Mediastinal contour | Width? Mass? |
| Pleura | Effusion, thickening, calcification |
| Bones | Lesions or fractures; always assess for symmetry |
| Soft tissues | Don’t miss a mastectomy |
In practice: a hazy, blurry, washed-out white lung, a blunted costophrenic angle, a jet-black area with no lung markings, a trachea off the midline, or a heart wider than half the chest on a posteroanterior film: “that ain’t right.” Section 17.8 names the pattern.
17.7 · Objective d — The imaging modalities compared
| Modality | Used for | Cautions |
|---|---|---|
| Chest radiograph | First line for almost every pulmonary or cardiac complaint | No true contraindications; pregnancy test, lead shielding, lifetime dose |
| Pulmonary ultrasound | Almost exclusively trauma: collapsed lung (pneumothorax) or fluid; part of the extended focused assessment with sonography for trauma; procedures | No contraindications |
| Computed tomography | An inconclusive radiograph with a continuing problem (most common); suspected pulmonary embolism; trauma; chronic obstructive pulmonary disease and interstitial lung disease; bone; cancer screening | Pregnancy (still done when emergent); contrast cautions below |
| Computed tomography angiogram | First for a suspected pulmonary embolism; pulmonary hypertension, vasculitis, scleroderma | Needs iodinated contrast |
| Ventilation/perfusion scan | Pulmonary embolism when the angiogram cannot be done, primarily contrast allergy | Inferior to the angiogram |
| Single-photon and positron emission tomography | Usually secondary to the radiograph; positron emission tomography mostly for metastases, now mostly done with computed tomography | Positron emission tomography costs more |
| Magnetic resonance imaging | A mass inconclusive on computed tomography; those who cannot have computed tomography; vasculopathy (second choice); intramural hematoma; superior for vasculitis | Non-titanium metal implants, gadolinium allergy (rare), claustrophobia |
The chest radiograph: indications and safety
Indications (there are others): chest pain; shortness of breath; dyspnea on exertion; any cough longer than 6 weeks with no explanation; unexplained weight loss in any chronic smoker; hemoptysis; adventitious lung sounds on auscultation; support hardware evaluation (invasive lines, tubes, a pacemaker). These may warrant computed tomography, but the radiograph is first line, and the findings decide whether computed tomography follows. When is computed tomography first? Only for a suspected pulmonary embolism: a computed tomography angiogram.
- ★ Contraindications to radiographs: there are none (no true contraindications).
- The American College of Radiology recommends limiting lifetime diagnostic radiation to 100 millisieverts, equal to about 10,000 chest radiographs or 25 chest computed tomography scans.
- ★ Always, always, always order a beta human chorionic gonadotropin urine or blood test on every female of potential childbearing age. Pregnancy is not an absolute contraindication.
- Lead-shield any area not being filmed, especially radiation-sensitive organs: thyroid, ovaries, testes, breasts, fetus.
Pulmonary ultrasound
Used almost exclusively in trauma to assess for a collapsed lung (pneumothorax) or fluid, very often in the emergency department and trauma bay as part of the extended focused assessment with sonography for trauma. It can be used for procedures. Contraindications to pulmonary ultrasound: there are none. On the image the ribs cast a dark shadow beneath them; the bright pleural line runs between them with the lung parenchyma below.

Computed tomography: attenuation, indications and contrast
Structures are termed high attenuation (bright) or low attenuation (dark), analogous to radiopaque and radiolucent (or hyperechoic and hypoechoic on ultrasound).
| Low attenuation (dark) | Normal | High attenuation (bright) |
|---|---|---|
| Air and gas; fluid; coagulated blood from a hemorrhage (it coagulates quickly in the lungs from the exposure to air) | Heart and muscle | Bone (very high); fresh blood from a hemorrhage; contrast material, which is why it is used: to find areas a non-contrast scan may miss |

Indications for computed tomography: an inconclusive radiograph in a patient with a continuing pulmonary issue (the most common reason); suspected pulmonary embolism; trauma (contrast can be used with suspected bleeds but is often not needed); chronic obstructive pulmonary disease and interstitial lung disease; bone (it is the best modality for bone, so if a radiograph is inconclusive it is the best study to rule out spinal and rib fractures); and cancer screening. Computed tomography of the head and neck is done for possible upper airway obstruction, such as a retropharyngeal abscess or a foreign body not detected by radiograph.
Indications for contrast: suspected vascular pathology (pulmonary embolism, dissection, aneurysm); concern for a focal lesion (tumor, tuberculoma, lung abscess); the -itis conditions (vasculitis, although magnetic resonance is superior for it; pneumonitis, bacterial bronchitis, neck abscess); and metastases, because contrast is good for showing involved lymph nodes, of which there are a great many in the neck.
Cautions. ★ Imaging modalities have few to no true contraindications. Pregnancy: in emergent situations imaging is still done, even with contrast (for example, a pulmonary embolism). Cautions before iodinated contrast: anaphylaxis to medicines; ★ anaphylaxis to shellfish not yet tested for iodine allergy versus the shellfish itself is a caution before iodinated contrast; anaphylaxis or angioedema to iodine; a high creatinine or blood urea nitrogen (contrast is supposed to be cleared by the kidneys and is nephrotoxic); and suspected thyroid dysfunction.
Single-photon and positron emission tomography
- Positron emission tomography scans are higher resolution and higher sensitivity than single-photon emission computed tomography, and more expensive. Both are used quite often but are usually secondary to the chest radiograph.
- Positron emission tomography is mostly used to identify metastases of cancer, here lung cancer; because the lungs are often a site of metastases, it is sometimes important in many other cancers too.
- It is now done mostly as a combined scan with computed tomography, which gives a much clearer image.

Who reads it: a scan is usually analyzed in the axial plane first, then coronal, then sagittal. The ordering clinician always gets an official read from the radiologist, but clinician reads in acute care settings are often done for rapid intervention, which applies almost entirely to computed tomography, radiographs and ultrasound. The clinician’s read is often just for the answer, not the whole image: suspecting a collapsed lung, you may not spend time on the esophagus or trachea.
The ventilation/perfusion scan
- Used primarily to find pulmonary emboli; an option when you cannot use contrast computed tomography or magnetic resonance.
- ★ It is inferior to the computed tomography angiogram, done when the angiogram cannot be performed, primarily for contrast allergy.
- Ventilation: the patient inhales a radioisotope tracer, technetium-99m (as DTPA, diethylenetriaminepentaacetic acid), through a nebulizer and is imaged. Perfusion: technetium-99m macroaggregated albumin is injected into the venous circulation and the patient is imaged again.
- The two are compared, and the result is a low, medium or high probability of pulmonary embolism.



Magnetic resonance imaging
- Contraindications and precautions: metallic implantable devices that are not titanium; allergy to gadolinium (if using contrast; rare); claustrophobia.
- Magnetic resonance is the king of soft tissue, but the unique anatomy of the lungs makes computed tomography usually first line, even when ruling out cancer. There are not many primary pulmonary indications.
- Typically used for a mass inconclusively seen on computed tomography; secondarily in those who cannot have computed tomography; a secondary choice for vasculopathy; and superior to the computed tomography angiogram for intramural hematomas (blood collected between the tissue layers of the artery wall).
- Read in the same fashion as computed tomography. T1 uses shorter intervals between pulses, T2 longer, and FLAIR (fluid-attenuated inversion recovery) very long, letting abnormalities appear bright while cerebrospinal fluid stays dark. Fat is bright on T1 and light to dark on T2; air is always very dark; inflammation is dark on T1 and bright on T2.


17.8 · Objective e — The five patterns
| Condition | On the chest radiograph | On computed tomography |
|---|---|---|
| Pneumonia | Consolidation (also called infiltrate): white, filled-in lung where it should be dark | Consolidation in the affected lobe |
| Pleural effusion | ★ Blunted costophrenic angles: the sharp V is lost | A gray fluid collection in the pleural space compressing the lung |
| Pulmonary edema | Cephalization of vessels, ★ Kerley B lines, pleural effusion, an increased cardiothoracic ratio | Kerley B lines can show on computed tomography too |
| Pneumothorax | Jet black air with the compressed lung beside it | Black air in the pleural space compressing the lung |
| Interstitial lung disease | ★ Diffuse, abnormal patterns in the lung tissue (the interstitium) rather than the air sacs | Reticular, nodular, honeycombing, volume loss, traction bronchiectasis, ground-glass, Kerley B lines (below) |
Pneumonia
Pneumonia shows as consolidation (the lecture also used infiltrate): the air-filled lung is replaced by white. The deck shows normal, bacterial, viral and COVID-19 pneumonia films side by side, but the lecture said not to get into the minutia of which is which; the patient’s history and how sick they look tell those apart.


Pleural effusion
Fluid collects in the pleural space, between the layers of the pleura. The hallmark on the film is blunted costophrenic angles: the normally sharp V at each base is lost. On a film alone an effusion can be hard to tell from consolidation; the history (shortness of breath, an older patient, heart failure) raises the suspicion.


Pulmonary edema
The film shows cephalization of vessels (prominent upper-lung vessels), Kerley B lines, pleural effusion and an increased cardiothoracic ratio. ★ Kerley B lines are short, thin, horizontal lines seen on chest radiographs or computed tomography, at the outer edges of the lower lungs, caused by thickening of the interlobular septa (the walls separating the tiny lobules of the lung).


Pneumothorax
Air in the pleural space is jet black on the radiograph, with no lung markings in it, and the compressed lung sits beside it.


Interstitial lung disease
Radiographs for interstitial lung disease typically show diffuse, abnormal patterns affecting the lung tissue (the interstitium) rather than the air sacs. On computed tomography the report uses these terms:
| Term | What it looks like |
|---|---|
| Reticular opacities | A net-like, lattice appearance |
| Nodular or reticulonodular pattern | Tiny dots or small bumps scattered throughout the lungs |
| Honeycombing | Ring-like or cystic spaces, usually 3 to 10 millimeters |
| Volume loss | Shrunken lung fields or elevated diaphragms |
| Traction bronchiectasis or distortion | Pulled-open airways or distorted lung architecture caused by fibrotic pull |
| Ground-glass opacities | Hazy, pale areas where the lung density is increased |
| Kerley B lines | Short, horizontal lines at the outer edges of the lower lungs |


18 · Pulmonary Function Testing and Oxygenation
Professor Fowler, MMS, PA-C · 26 October 2026
Instructional Objectives
Topic Outline 18: Pulmonary Function Testing and Oxygenation (the calendar prints it as Lecture #20; the syllabus numbers it 18)
- Describe pulmonary function testing parameters.
- Discuss indications for pulmonary function testing.
- Differentiate obstructive and restrictive pulmonary patterns.
- Interpret basic pulmonary function study results.
- Explain the role of pulmonary function testing in diagnosis and monitoring of pulmonary disease.
- Discuss pulse oximetry and oxygenation assessment.
The one-line frame for the whole lecture. Pulmonary function tests measure how air moves (flow), how much the lungs hold (volume) and how well gas crosses into the blood (gas transfer). Three standard tests answer three questions: spirometry for obstruction (trouble getting air OUT), lung volumes for restriction (trouble getting air IN, so less volume), and the diffusing capacity for carbon monoxide for pulmonary vascular disease (gas transfer). Read a report in order: the ratio first, then the forced vital capacity, then the total lung capacity.
Abbreviations you will see on every report: FEV1 (forced expiratory volume in one second), FVC (forced vital capacity), FEV1/FVC (forced expiratory volume in one second over forced vital capacity, “the ratio”), TLC (total lung capacity), RV (residual volume), FRC (functional residual capacity), DLCO (diffusing capacity of the lung for carbon monoxide), PEFR (peak expiratory flow rate), COPD (chronic obstructive pulmonary disease).
| In the recording | So |
|---|---|
| On the objectives: “Differentiate obstructive and restrictive pulmonary patterns. That’s going to be the important ones.” [2:22–2:27] | Objective c (18.5) and reading the result (18.6) carry the weight. |
| Whole-body plethysmography: “Now this is important”; “the key thing here is one of the lung volumes that we all possess is the residual volume.” [13:54–14:28] | Plethysmography measures the total lung capacity, the functional residual capacity, the residual volume and airway resistance (18.1). |
| The spirometry tracing: “This I want you to see in your sleep. I want you to have dreams about this … get this tracing in your head.” [24:40–24:57] | The four volumes and four capacities on one tracing (18.2). |
| “Probably the most important thing I want you guys to remember … the most important part of interpreting PFTs, and that is the FEV1 to FVC ratio.” And: “the FVC and the FEV1 and the FEV1 to FVC ratio are the three most important values you need to know about when interpreting PFTs.” [35:39–35:57; 39:40–39:55] | The three values (18.3); the ratio is the first step of every read (18.6). |
| The flow-volume loop: “another visual graph that you’ve just got to burn into your brain … if you know what the normal looks like, then you’re going to know what the abnormal looks like.” [36:38–36:50] | Know the normal loop cold (18.3), then the abnormal ones (18.5). |
| The obstructive volume-time curve: “That’s very important. Get that visual in your mind. That’s what an obstructive time-volume pattern looks like.” [44:49–44:54] | A slow rise and a long, late plateau (18.5). |
| “If the FEV1/FVC ratio is less than 70%, it ain’t normal … 70% is your marker.” Notability’s transcript also has “Pay attention to this.” [53:11–53:41] | A ratio below 70% is obstruction (18.5, 18.6). |
| “If there’s a scoop in the loop, there’s obstruction. Remember that.” And the restrictive loop: “if it looks like a witch’s hat, it’s restricted.” [57:50–58:15] | The two loop shapes to recognize at a glance (18.5). |
| “The key thing to remember about restrictive lung disease is what? Hard to get it in.” And: “They look the same, it’s just the volume is less. That’s the key thing to remember with restrictive pathology.” [49:27–49:36; 1:01:19–1:01:29] | Restriction keeps the normal shape at a smaller size (18.5). |
| Bronchiectasis: “now if you remember this, this is a permanent airway dilation.” [7:58] | Bronchiectasis is obstructive (18.5). |
Said to be beyond what you need: the incentive spirometer’s piston (“Don’t worry about this,” 20:57); how the diffusing capacity is measured (“it’s all a lot of math. But we’re not going to focus in on that today,” 23:13; its role is still asked, 18.7); pulmonary vascular disease beyond its definition (6:58); digging into the table of normal values (“I’m not going to be digging into this,” 43:19), and normal ranges are always supplied on the exam anyway. The lecturer also said of the ratio “you need to know how to calculate that” (36:30); the quizzes give the ratio rather than ask you to work it out, following the course rule that nothing is calculated.
Where the time went (minutes of speech, 62 in all, both transcripts): the parameters (objective a: the equipment, plethysmography, the volumes and capacities with the class breathing them, spirometry, the forced values, the curves) about 27 minutes; obstructive against restrictive (c) about 16; reading results (d) about 6; pulse oximetry and oxygenation (f) about 4; indications (b) and the role of each test (e) about 3 each; the opening case and objectives about 3. The recording ends as the three cases begin (1:02:09, “this represents three different patients”): slides 46 to 57 (Cases 1 to 3) have no audio, so they are taught here from the slides alone (18.6). The quizzes are weighted the same way, with reading results lifted because it is the core of the vignettes.
Where the slide and the recording differ. (1) Repeated efforts: slide 24 says the test is repeated 3 times and the highest volumes and flows are recorded; the recording said it is repeated “to get a general average of it” (33:22). The slide is keyed. (2) Slide 39’s numbers: the forced expiratory volume in one second is 0.94 measured against 1.90 predicted, 49% of predicted on the slide; the recording said “44% predicted” (48:04, both transcripts). The slide is keyed. (3) The diffusing capacity was described as measuring “how much carbon dioxide got transferred into the blood” (23:07, both transcripts); the test, as its name on slide 18 says, uses carbon monoxide. Not asked beyond the slide. (4) The ratio’s definition: slide 26 calls it the proportion of the total lung capacity exhaled in the first second, then adds “(% of the FVC exhaled in 1 sec.)”; the recording repeated “total lung capacity” (36:06). The ratio is built from the forced vital capacity, as its name and the slide’s own parenthesis say, and that is how it is taught and asked. (5) Slide 30 says the loop’s “complete cycle represents the TLC”, while the same figure labels the loop’s width VC (vital capacity); the residual volume is never exhaled, so the loop spans the vital capacity. Not asked. (6) Slide 23 writes the functional residual capacity as “Expiratory Residual Volume (ERV) + RV”; it is the expiratory reserve volume (slide 21), as taught here. (7) Normal ratio: slide 31 gives a normal ratio of more than 80% and below 70% as obstruction; slide 41 puts restriction at 70% or more. The quizzes use ratios clearly below 70% or above 80%. (8) The recording called plethysmography “the only form of testing” that gives the residual volume (14:51); the slide lists the residual volume among what plethysmography measures and makes no “only” claim, so none is asked. (9) The two transcripts disagree at 46:46 (ours “inspiration, aspiration”, Notability’s “inspiration, expiration”); the loop has an inspiratory and an expiratory limb.
18.1 · Objective a — The equipment and the tests: what each one measures
Pulmonary function testing equipment refers to the devices used to measure lung volume, airflow, airway resistance, gas exchange, oxygenation and ventilation. Common examples are spirometers, peak flow meters, body plethysmographs, gas analyzers, blood gas analyzers, pulse oximeters and calibration tools (the calibration syringe). Accurate testing depends on properly calibrated equipment, clean components and correct patient technique.

| Device or test | What it measures |
|---|---|
| ★ Whole-body plethysmography (the patient sits in a glass booth) | The total lung capacity (the maximum amount of air the lungs can hold), the functional residual capacity (the air left after a normal, passive exhalation), the residual volume (the air remaining after exhaling as much as possible) and airway resistance (how hard it is for air to flow through the bronchial tubes) |
| Spirometer (handheld or desktop) | Airflow and some lung volumes (18.3) |
| Peak flow meter | Peak expiratory flow; it correlates with the forced expiratory volume in one second and is used at the bedside or at home, for example in asthma |
| Blood gas analyzer | Gas exchange and oxygenation from a blood sample: its readout shows the pH, the partial pressures of carbon dioxide and oxygen, and bicarbonate (18.8) |
| Pulse oximeter | Oxygenation (the readout shows the oxygen saturation and the pulse rate), from a small fingertip clip; one is shown “for home use” (18.8) |


Standard and specialized pulmonary function tests
| Standard tests | Responsible for diagnosing |
|---|---|
| Spirometry, including the flow-volume loop | Obstructive lung disease |
| Lung volumes | Restrictive lung disease |
| Diffusing capacity for carbon monoxide: it measures the integrity of the alveolar-capillary membrane | Pulmonary vascular disease |
Specialized tests: the arterial blood gas; exercise oximetry (at rest and with modest activity; quick and cheap); the six-minute walk test (walking as far as possible in 6 minutes, to monitor response to treatment as well as prognosis); peak flow (at the bedside, to measure the maximum expiratory airflow delivered in a single breath, as in asthma); and the maximal inspiratory and expiratory pressures (diaphragmatic strength and the neurologic side of breathing).
18.2 · Objective a — The four lung volumes and the four lung capacities
To interpret pulmonary function tests, first know what they measure. A volume is one compartment; a capacity is a sum of volumes. ★ Know this tracing well enough to see it in your sleep.

| Volume | Definition | Typical size (slide) |
|---|---|---|
| Tidal volume | The air moved in and out with each normal restful breath (tidal breathing) | About 500 mL, varying with age, sex and size |
| Inspiratory reserve volume | The additional volume breathed in on top of the tidal volume | 3000 to 3300 mL |
| Expiratory reserve volume | The additional volume breathed out after a normal breath out | |
| Residual volume | The air still remaining in the lung after maximal expiration; it can never be breathed out | 1200 mL |
| Capacity | Which volumes | Meaning (slide size) |
|---|---|---|
| Inspiratory capacity | Tidal volume + inspiratory reserve volume | The breath that can be drawn in from the end of a quiet breath out |
| Functional residual capacity | Expiratory reserve volume + residual volume | The air left in the lungs at the end of a quiet breath out, with all the respiratory muscles fully relaxed (2200 to 2400 mL) |
| Vital capacity | Tidal volume + inspiratory reserve volume + expiratory reserve volume | Everything except the residual volume: the deepest breath in to the fullest breath out (4500 to 5000 mL) |
| Total lung capacity | All four volumes: tidal + inspiratory reserve + expiratory reserve + residual | The maximum volume the lungs can hold (5700 to 6200 mL) |
Total lung capacity is the sum of all four volumes. Total lung capacity, the maximum volume the lungs can hold, is the sum of all four volumes: tidal, inspiratory reserve, expiratory reserve and residual.
Reading the tracing: from the top of a quiet breath up to the peak of the deepest breath is the inspiratory reserve volume; the small rise and fall of each quiet breath is the tidal volume; from the end of a quiet breath out down to the lowest point of the fullest breath out is the expiratory reserve volume; below that lowest point is the residual volume. The expiratory reserve volume plus the residual volume (from the end of a quiet breath out to the bottom) is the functional residual capacity.
18.3 · Objective a — Spirometry: how it is done and the forced values
Spirometry is used to measure air flow and some lung volumes. The patient places the mouth around the mouthpiece, inhales maximally, then exhales forcefully, as fast as possible, and continues for at least 6 seconds. The effort is repeated 3 times, and the highest air volumes and flows are recorded.
| Value | Definition |
|---|---|
| Forced vital capacity | The total volume of air a person can forcefully and rapidly exhale after a maximal deep breath; the maximum exhaled volume, typically reached in about 6 seconds |
| Forced expiratory volume in one second | The amount of air forcefully blown out in the first second of the breath out |
| ★ The ratio (forced expiratory volume in one second over forced vital capacity) | A calculated measurement: the percentage of the forced vital capacity exhaled in the first second. Normal is more than 80%; below 70% indicates obstruction |
| Peak expiratory flow rate | The maximum velocity created during forced expiration: the maximum slope of the volume-time curve, the top of the flow-volume loop |
| Forced expiratory volume in 6 seconds | The volume blown out by 6 seconds |
| Forced expiratory flow 25% to 75% | The average flow over the middle half of the forced vital capacity: from the point at which 25% of it has been exhaled to the point at which 75% has |
The spirometry breath out. After a maximal breath in, the patient exhales forcefully, as fast as possible, and keeps going for at least 6 seconds.
★ The forced vital capacity, the forced expiratory volume in one second and the ratio of the two are the three most important values in interpreting pulmonary function tests.
The two graphs
The volume-time curve plots exhaled volume against time: it rises steeply and then plateaus. The volume at 1 second is the forced expiratory volume in one second; the plateau is the forced vital capacity; the steepest slope is the peak expiratory flow rate. Normally more than 80% of the forced vital capacity is expired in the first second.

The flow-volume loop is the graph that plots airflow against lung volume during a forced inhalation and expiration in spirometry. The expiratory limb is above the axis and the inspiratory limb below it; the top of the expiratory limb is the peak expiratory flow, and from it the normal expiratory limb falls in a straight line to the volume axis. ★ Know the normal loop, and the abnormal ones follow.

| Normal values (95% confidence interval; the exam supplies ranges) | Percent of predicted |
|---|---|
| Forced expiratory volume in one second; forced vital capacity | 80% to 100% |
| Absolute ratio | Within 5% of predicted |
| Total lung capacity | 80% to 120% |
| Functional residual capacity; residual volume | 75% to 120% |
| Diffusing capacity for carbon monoxide | More than 60% (the slide: “>60 to >120%”) |
18.4 · Objective b — Indications: why order pulmonary function tests?
- Diagnosis of symptomatic disease. The most common reason to order pulmonary function tests is to help make a diagnosis in a patient presenting with a pulmonary symptom such as chronic shortness of breath, cough, or unexplained hypercapnia or hypoxemia, for example smokers and those with occupational exposures.
- Pulmonary function tests do NOT provide a specific diagnosis. They show what pathophysiological derangement the underlying disease is causing and help rule out parts of the differential.
- Prognosis: they can help determine the prognosis in a patient with known disease.
- Surgical risk: they can estimate surgical risk in patients facing lung resection or with chronic obstructive pulmonary disease.
- Screening: they can screen for early, asymptomatic complications from non-pulmonary diseases such as autoimmune diseases or from medication, for example long-term amiodarone, which can cause significant pulmonary toxicity.
18.5 · Objective c — Obstructive against restrictive: the physiology, the curves and the loops
As a diagnostic tool, pulmonary function tests classify diffuse lung disease into three categories: obstructive, restrictive and pulmonary vascular (gas transfer impairment).
| Physiology | What goes wrong | Examples |
|---|---|---|
| Obstructive: decreased airflow | Increased airway resistance: air gets in but has trouble getting OUT | Chronic obstructive pulmonary disease (chronic bronchitis, emphysema); asthma; asthmatic or chronic obstructive bronchitis; ★ bronchiectasis (permanent airway dilation, resulting in chronic inflammation, recurrent infections and increased airway resistance); cystic fibrosis |
| Restrictive: a decrease in volume | Poor compliance of the respiratory system or neuromuscular impairment: the lungs need more effort to expand than normal, so the breaths are shallow (trouble getting air IN) | Interstitial lung diseases (pulmonary fibrosis, sarcoidosis); chest wall pathology (obesity, kyphosis, scoliosis); neuromuscular diseases (amyotrophic lateral sclerosis, muscular dystrophy), which impair lung function through weakness of the respiratory muscles rather than poor compliance. The restrictive list also names beryllium disease, congestive heart failure, idiopathic pulmonary fibrosis, interstitial pneumonitis, neuromuscular diseases, sarcoidosis and thoracic deformities |
| Gas transfer impairment (pulmonary vascular) | Normal breathing mechanics; the problem is oxygen and carbon dioxide moving across the alveolar-capillary membrane, or the pulmonary blood flow (delivery of hemoglobin to the membrane) | Pulmonary hypertension; chronic thromboembolic disease; early emphysema; early interstitial lung disease |
The categories are NOT mutually exclusive. Chronic obstructive pulmonary disease can have both obstructive and vascular components; sarcoidosis can be restrictive, obstructive and vascular.
Two breathless patients
Patient A, a 62-year-old former smoker with dyspnea on exertion and wheezing: the film is hyperinflated with flat diaphragms, which fits obstruction. Patient B, a 66-year-old nonsmoker with dyspnea on exertion, a dry cough and “Velcro” crackles: small-volume lungs with reticular opacities, which fits restriction, confirmed by a low total lung capacity.


The result table
| Forced expiratory volume in one second | Forced vital capacity | The ratio (Tiffeneau index) | |
|---|---|---|---|
| Obstructive lung disease | Normal (very mild obstruction) or decreased (moderate or severe) | Normal (mild or moderate obstruction) or decreased (severe) | Decreased, below 70% |
| Restrictive lung disease | Normal or decreased | Decreased | Normal or increased, 70% or more |

Why the ratio falls in obstruction: the ratio is the percentage of the forced vital capacity exhaled in the first second, and in obstruction it takes longer to push the air out, so the forced expiratory volume in one second drops proportionally more than the forced vital capacity and the ratio falls below 70%. In restriction the forced vital capacity is the value that is decreased, so the ratio stays normal or rises. ★ 70% is the marker.
The volume-time curve in each pattern
- Normal: a steep rise, more than 80% of the forced vital capacity out in the first second, then a plateau.
- ★ Obstruction: a slow rise, no steep first second, and a long, late plateau (mild: late plateau, forced vital capacity preserved; severe: no plateau, forced vital capacity reduced). The obstructive pattern is determined by the ratio.
- ★ Restriction: the normal shape, a steep rise and a normal plateau, but at a lower volume (forced vital capacity reduced): the air comes out easily, there is simply less of it.



The flow-volume loop in each pattern
- Normal: a quick rise to a sharp peak, then an expiratory limb that falls in a straight line.
- ★ Obstruction: “a scoop in the loop”: the expiratory limb is scooped (concave) after the peak. The deformity is called coving. Mild obstruction: peak expiratory flow mildly reduced, with coving. Severe obstruction: peak expiratory flow severely reduced, the limb collapsing into a long flat tail, with coving.
- ★ Restriction: narrow and tall with a sharp point, like a witch’s hat; everything is smaller because less volume moves. Peak expiratory flow is normal or mildly reduced, and there is no coving.
- Gas transfer impairment keeps normal breathing mechanics, so its curves and loops look normal; the diffusing capacity finds it (18.7).






18.6 · Objective d — Interpreting a report: the stepwise read and three cases
A report is a page of numbers. Read it in order:
- Assess the ratio (forced expiratory volume in one second over forced vital capacity) first.
- If the ratio is low, assess the forced vital capacity: low forced vital capacity = obstruction or mixed (severe obstruction can reduce the forced vital capacity too); normal forced vital capacity = obstruction.
- If the ratio is normal or high, assess the forced vital capacity: low = possible restriction; normal or high = normal lung mechanics.

| Very basic interpretation | Reads as |
|---|---|
| Low ratio | Obstruction |
| Low total lung capacity | Restriction (lung volumes, the standard test for restriction, confirm it) |
| Low ratio and low total lung capacity | Obstruction and restriction: a “mixed defect” |
A low total lung capacity is restriction. A low total lung capacity is restriction; with a normal ratio there is no obstruction alongside it.
Grading obstruction (examples): as obstruction worsens, the forced expiratory volume in one second, the ratio and the peak flow all fall: normal about 4.0 to 6.0 L, ratio 80 to 90, peak flow 550 to 650 L/min (men) or 400 to 500 (women); mild 3.0 L, 70, 300 to 400; moderate 1.6 L, 50, 200 to 300; severe 0.6 L, 40, 100 (slide 35).
A restrictive example (slide 39): forced vital capacity 0.96 L measured against 2.75 L predicted (35% of predicted); forced expiratory volume in one second 0.94 against 1.90 (49%); the ratio 98% against a predicted 69%; forced expiratory flow 25% to 75% 2.25 against 2.11 (107%); peak expiratory flow 2.98 against 5.40 (55%). A normal or high ratio with a low forced vital capacity: possible restriction.
Case 1 (no audio): a 56-year-old smoker
A productive cough and dyspnea for more than 3 months; thin, comfortable; oxygen saturation 95% on room air; diminished breath sounds throughout both lungs. The report: the ratio is 52% against a reference of 82% (low), so assess the forced vital capacity: 2.3 L, 61% of reference (low), which reads as obstruction or mixed. The total lung capacity is 7.1 L, 120% (not low; the residual volume is 216%), so this is obstruction, not a mixed defect. The flow-volume loop is scooped. The diffusing capacity is 73%. Testing before and after 4 puffs of albuterol changes little.

Case 2 (no audio): a 32-year-old animal trainer
A progressive dry cough and dyspnea for the past month; mild respiratory discomfort; heart rate 104, respiratory rate 28, oxygen saturation 88% on room air; fine crackles throughout both lungs. The report: the ratio is 94% against a reference of 84% (normal or high), and the forced vital capacity is 1.7 L, 39% (low): possible restriction, confirmed by a total lung capacity of 2.5 L, 44%. The diffusing capacity is low, 38% (10 against 26): gas is not crossing the alveolar-capillary membrane normally. The loop is narrow.

Case 3 (no audio): a 15-year-old boy with a spinal cord injury
Dyspnea for 2 months; mild respiratory discomfort; oxygen saturation 92% on room air; chest clear to auscultation. The report: the ratio is 86% against a reference of 86% (normal), the forced vital capacity 3.5 L, 71% (low) and the total lung capacity 4.4 L, 67% (low): restriction. The diffusing capacity is normal, 97%, so the alveolar-capillary membrane is intact: restriction with a normal diffusing capacity. Note the restrictive loop. (The slides list neuromuscular weakness among the routes to restriction but do not name the cause in this case, so the cause is not asked.)

18.7 · Objective e — The role of pulmonary function testing in diagnosis and monitoring
What the tests examine. Pulmonary function tests provide information about every component of respiration: patency of the airways (large and small airways); the parenchyma (alveoli and interstitium); the pulmonary vasculature; the bellows and pump mechanism (the diaphragm and chest wall); and the neural control of ventilation (is the brain telling the lungs to breathe as deeply and frequently as it should?).
In diagnosis they classify diffuse lung disease as obstructive, restrictive or pulmonary vascular (18.5), and each standard test answers one of those questions: spirometry with its flow-volume loop diagnoses obstruction; lung volumes diagnose restriction; the diffusing capacity for carbon monoxide, which measures the integrity of the alveolar-capillary membrane, diagnoses pulmonary vascular disease. So when spirometry and lung volumes are normal but a gas transfer problem (pulmonary hypertension, for example) is suspected, the next test is the diffusing capacity; when spirometry suggests restriction, the next test is lung volumes for the total lung capacity. The tests show the derangement, not a specific diagnosis, and they do not replace the history.
Lung volumes diagnose restriction. Lung volumes are the standard test responsible for diagnosing restrictive lung disease; spirometry diagnoses obstruction and the diffusing capacity pulmonary vascular disease.
In monitoring, the six-minute walk test monitors response to treatment as well as prognosis; the peak flow meter follows expiratory airflow at the bedside or at home, as in asthma; and pulmonary function tests help judge the prognosis of known disease (18.4).
18.8 · Objective f — Pulse oximetry and oxygenation assessment
The slides cover oxygenation through the equipment and the specialized tests:
- The pulse oximeter is pulmonary function equipment that measures oxygenation: a small clip on the fingertip, shown as suitable for home use.
- The blood gas analyzer measures gas exchange and oxygenation from a blood sample (its readout: the pH, the partial pressures of carbon dioxide and oxygen, and bicarbonate); the arterial blood gas is one of the specialized pulmonary function tests (with exercise oximetry, the six-minute walk, peak flow and the maximal pressures), not a standard one.
- Exercise oximetry checks oxygenation at rest and with modest activity, and it is quick and cheap.
- The cases record the oxygen saturation on room air (95%, 88% and 92%) with the vital signs.

The deck gives no normal range for the oxygen saturation; the exam would supply one.
19 · Acid-Base Balance and Blood Gas Interpretation
Professor Megan B. Finck, MMS, PA-C · 27 October 2026
Instructional Objectives
Topic Outline 19: Acid-Base Balance and Blood Gas Interpretation
- Compare and contrast laboratory studies used to diagnose acid-base disorders.
- Explain differences between arterial and venous blood gas measurements.
- Discuss indications for arterial blood gas testing.
- Interpret arterial blood gas results.
- Describe expected findings in:
- Metabolic acidosis
- Metabolic alkalosis
- Respiratory acidosis
- Respiratory alkalosis
- Calculate the anion gap.
- Discuss the clinical significance of an abnormal anion gap.
The one-line frame for the whole lecture. The arterial blood gas assesses three things: oxygenation (the oxygen), ventilation (the carbon dioxide) and acid-base status (the pH, the bicarbonate and the carbon dioxide). Read it step by step: the pH first (low is acidosis, high is alkalosis), then which values are outside the normal range: a primary change in the carbon dioxide is a respiratory disorder (the lungs), a primary change in the bicarbonate is a metabolic one (nonvolatile acids, bicarbonate and the kidney); then ask whether the labs fit the patient. From the electrolytes, the anion gap is sodium minus (chloride plus bicarbonate).
Abbreviations you will see on a blood gas report: ABG (arterial blood gas), pH, PaCO2 (arterial partial pressure of carbon dioxide) and PvCO2 (venous partial pressure of carbon dioxide), PaO2 (arterial partial pressure of oxygen) and PvO2 (venous), SaO2 (arterial oxygen saturation), HCO3− (bicarbonate), FiO2 (fraction of inspired oxygen), COHb (carboxyhemoglobin), AG (anion gap), CBC (complete blood count), CMP (comprehensive metabolic panel). The letter after the P names the sample: a for arterial, v for venous.
| In the recording | So |
|---|---|
| The sample: “most commonly where you’re going to see this taken is from the radial artery, and this is where our Allen test comes into play.” [6:27–6:35] | The radial artery is the usual site; check the collateral supply first (19.3). |
| “If we’re trying to understand how well our patient’s oxygenating, we need to know how many red blood cells there are to actually carry the oxygen.” And: “98% of the oxygen is going to be tied up to that hemoglobin.” [13:07–13:16; 22:18] | The oxygen pressure is only the dissolved oxygen; 98% rides on hemoglobin (19.1). |
| The inspired oxygen: “remember this is directly influenced by our fraction of inspired oxygen” [40:15]; and “One thing that you have to know with this … is my patient on any supplemental oxygen?” [1:00:38–1:00:50] | Record room air or the supplemental oxygen with every sample (19.3); the oxygen pressure moves with it (19.1). |
| pH 7.35 to 7.45: “I want you to tattoo that on your eyeballs … one of the most important ranges to remember.” Carbon dioxide 35 to 45: “another one to tattoo on your eyeballs … because you will use that in calculations.” [33:17–33:22; 37:46–37:51] | Know what normal looks like; on the exam every value comes with its range (the table in 19.5). |
| “The first thing, not the only thing, but the first thing we look at is the pH level … So step one, pH. Step two, CO2.” [36:46–37:42] | The step-wise read (19.5). |
| “Don’t just look at the pH … Does their pH match their clinical picture?” [36:13–36:25] | The third step: do the labs fit the patient? Treat the patient, not the labs (19.4, 19.5). |
| “Your classic anxious patient hyperventilating, that’s what’s going on.” And the acids: “one of the classic examples … keto acids that are produced by patients with diabetes when they go into diabetic ketoacidosis.” [20:54–20:59; 31:07–31:13] | Anxiety lowers the carbon dioxide (19.5); ketoacids and lactic acids are the nonvolatile acids to know (19.1, 19.6). |
| “Those are the four primary conditions that I want you to set into your mind.” [56:25–56:49] | The four findings patterns (19.6). |
| The curve: “when it’s a left shift, it’s holding onto oxygen. When it’s a right shift, it’s letting go of the oxygen.” [1:06:19–1:06:25] | Alkalosis left, acidosis right (19.2). |
| Potassium and pH: “a very clinically important concept. Put a star on this slide.” [1:16:14–1:16:20] | Acidosis: hyperkalemia; alkalosis: hypokalemia (19.6). |
| The anion gap: “because this is included in the instructional objectives for this lecture, I do want you to memorize and understand this equation … if I were to give you a list of lab values and ask you to calculate the anion gap …” And: “If I ever have an anion gap that needs to be interpreted, I will give you a reference range with it.” [1:18:32–1:19:23] | The one calculation in this lecture: know the formula; the values (and the gap’s range) are given (19.7). |
Said not to be asked, or beyond what you need: the oxygen saturation thresholds of slide 36 (below 90% worrisome, below 75% critical): “I’m not going to ask you … my patient has an O2 saturation of 92%. Is this worrisome, or is this critical?” (1:01:57); memorizing every normal value (“you don’t need to know them all,” 18:19; slide 54’s first five rows are the ones she would like you to know, but “you’re gonna have reference ranges when you’re presented with clinical cases,” 1:28:50, and the course supplies them); the arterial stick in detail (“more detail really is coming during CPSS”, the Clinical Procedures and Surgical Skills course, 11:30); and the albumin correction as a calculation (“just know that it needs to be corrected if it’s abnormal,” 1:22:14). Winter’s formula, the delta-delta and the osmolar gap are not in this lecture.
Where the time went (minutes of speech, 90 in all): the laboratory studies and what each value measures (objective a: the order, the carbon dioxide and oxygen pressures, saturation, content, the dissociation curve, base excess, carboxyhemoglobin) about 29 minutes; interpreting results (d: pH, the definitions, the steps, what moves each pressure, compensation and the closing pearls) about 25; the four disorders (e) about 18, including potassium about 4; arterial against venous and the sample (b) about 8; the abnormal anion gap (g) about 5; the indications (c) about 2; the formula (f) about 2. Notability’s second transcript has text for the first segment only (0:00 to 47:13; its second segment is empty); where both exist they agree on the content.
Where the slide and the recording differ. (1) The arterial oxygen pressure’s normal: slide 14 says greater than 88 mm Hg; slides 23 and 54 say greater than 80, and both were said aloud (24:54, 40:26). The quizzes give the range with each value and use values clear of 80 to 88. (2) Kidney compensation was described as taking “days to weeks” (45:18); slide 50 says it occurs over days, as taught here. (3) The recording added that “compensation alone is not going to be enough to return the pH to normal” (46:30); slide 28 says the pH will try to normalize; not asked beyond the slide. (4) Base gain was illustrated with a bottle of antacid tablets as “bicarbonate of soda” (54:41); those tablets are calcium carbonate, and the slide’s cause is excessive bicarbonate administration. (5) Potassium was first said the wrong way round, then corrected aloud (“Sorry, backwards,” 1:13:12); slide 44 is taught here. (6) Hemoglobin’s affinity for carbon monoxide was called “an order of magnitude higher” (1:11:17); slide 42 gives 240 times. (7) The memory line for the metabolic labs came out as “when it’s acidosis, everything decreases. The alkalosis, everything decreases” (1:28:15); slide 53 has everything increasing in metabolic alkalosis. (8) The albumin correction was said to apply “if our albumin levels are up” (1:20:53); slide 48 corrects for albumin below 4.5 g/dL. (9) Slide 9’s double asterisks on sodium, potassium, calcium and chloride are explained only in the speaker notes and aloud (they come from a metabolic panel); not asked. (10) Heart failure sits on two slides: slide 26 lists congestive heart failure among the circulatory causes of respiratory acidosis, and slide 29 has mild failure (pulmonary edema, tachypnea) causing respiratory alkalosis and severe failure (hypoperfusion, lactic acidosis) a metabolic acidosis.
Where the physiology differs. Slides 15 and 24 list anemia among causes of a low oxygen pressure and polycythemia among causes of a high one. In physiology these change the oxygen content (how much hemoglobin there is to carry oxygen) more than the dissolved oxygen pressure; the quizzes do not ask either.
19.1 · Objective a — The arterial blood gas order and what each value measures
What an arterial blood gas is. A blood sample obtained from an artery that provides an assessment of normal body function and homeostasis. It is often used in combination with other assessments: vital signs, the physical examination, venous blood analysis (the complete blood count, the comprehensive metabolic panel and others), fluid intake, urine output and more.
What is usually included in an arterial blood gas order (always verify the contents of an order with the lab you are using): the pH; the partial pressures of carbon dioxide and oxygen; the oxygen saturation; the carbon dioxide content and the oxygen content; the base excess or deficit; bicarbonate; hemoglobin and hematocrit; carboxyhemoglobin; and the electrolytes sodium, potassium, calcium and chloride.
| Value | What it is | What it is used for |
|---|---|---|
| Partial pressure of carbon dioxide | The pressure exerted by dissolved carbon dioxide in blood | It indicates the efficacy of alveolar gas exchange in the lungs; it is used to detect respiratory abnormalities and to determine the alkalinity or acidity of the blood. It indicates the rate and depth of respirations and assesses alveolar ventilation. |
| Partial pressure of oxygen | The pressure exerted by oxygen dissolved in blood plasma: ★ less than 2% of the oxygen carried in blood is dissolved in plasma; 98% is bound to hemoglobin | It reflects the amount of oxygen passing from the alveoli to the blood. It is used to evaluate the ability of the lungs to oxygenate blood and to assess the efficacy of oxygen therapy. |
| Oxygen saturation | A ratio of the actual oxygen content of hemoglobin to the potential maximum oxygen-carrying capacity of hemoglobin | It indicates the relationship between oxygen and hemoglobin, not the oxygen content. It is also measured by pulse oximetry. Know the patient’s fraction of inspired oxygen: room air or supplemental oxygen? |
| Oxygen capacity | The maximum amount of oxygen that can combine with hemoglobin | The denominator of the saturation |
| Oxygen content | The actual amount of oxygen in the blood: 98% is transported in combination with hemoglobin, and the remainder is dissolved in the blood | Normal: arterial 15 to 22 vol% (15 to 22 mL/dL of blood); venous 11 to 16 vol% |
| Carboxyhemoglobin | Formed when hemoglobin is exposed to carbon monoxide; the affinity of hemoglobin for carbon monoxide is 240 times that of oxygen | Its results indicate the amount of carbon monoxide poisoning. Normal less than 2% of total hemoglobin; heavy smokers 6% to 8%; light smokers 4% to 5%. |
The carbon dioxide drives breathing
Carbon dioxide in the blood and cerebrospinal fluid is the major chemical factor regulating ventilation: as the carbon dioxide rises, ventilation increases. Extreme increases in the fraction of inspired carbon dioxide (more than 5%) can cause respiratory depression. So a carbon dioxide that keeps climbing while the breathing rate does not rise points to the respiratory center, which head trauma, anesthesia and drugs such as narcotics and barbiturates impair (19.5).
The inspired oxygen
★ The oxygen pressure is directly affected by the fraction of inspired oxygen: the amount of oxygen in the air being taken into the lungs. An increased fraction of inspired oxygen (supplemental oxygen) is a cause of an increased oxygen pressure; an insufficient one is a cause of a low oxygen pressure. That is why every sample is sent noting room air or the supplemental oxygen (19.3).
Where the hydrogen ions come from
pH is the negative logarithm of the hydrogen ion concentration in blood. The sources of hydrogen ions are volatile acids, for example carbonic acid (volatile acids can vary between liquid and gas), and nonvolatile acids, for example dietary acids, lactic acids and ketoacids. ★ Ketoacids (diabetic ketoacidosis) and lactic acids are the classic nonvolatile acids.
19.2 · Objective a — The oxygen-hemoglobin curve and base excess
Where the oxygen pressure is high, in the pulmonary capillaries, oxygen binds with hemoglobin. Where the oxygen pressure is low, in the tissue capillaries, oxygen is released from hemoglobin.

| pH | Curve | Hemoglobin and oxygen |
|---|---|---|
| High (alkalosis) | Left shift | Oxygen bonds more tightly to hemoglobin |
| Low (acidosis) | Right shift | Oxygen is released more easily from hemoglobin |
★ Left shift: hemoglobin holds on to oxygen. Right shift: it lets go. The curve shifts to the right with increased hydrogen ions, increased carbon dioxide, increased temperature and increased BPG (2,3-bisphosphoglycerate).

Base excess or deficit
Base excess is also called the whole blood buffer base: the sum of the concentration of buffer anions in whole blood. Bicarbonate represents half of the buffers available; other anions (for example plasma proteins and phosphates) represent the other half. It is critically important in determining respiratory against nonrespiratory changes in acid-base balance.
| Value (normal plus or minus 2 mEq/L) | Indicates |
|---|---|
| Positive | Base excess: a nonvolatile acid deficit, or a true base excess |
| Negative | Base deficit: a metabolic disturbance or nonvolatile acid excess (for example lactic acidosis, ketoacidosis), or a true base deficit |
Why base excess is reported. Base excess or deficit, the sum of the buffer anions in whole blood, is critically important in determining respiratory against nonrespiratory changes in acid-base balance.
19.3 · Objective b — Arterial against venous: why arterial, the sample and the venous values
Why arterial blood? Arterial blood provides a better mixture of blood. Venous blood is best for information more localized to the phlebotomy site and can be affected by temperature, perfusion, movement and local infection. Arterial blood indicates how well the lungs are oxygenating blood and whether the heart and circulation are failing. It does NOT indicate the degree of any abnormality: a physical assessment of the patient is needed (treat the patient and not the labs).
| Value | Arterial | Venous |
|---|---|---|
| Partial pressure of carbon dioxide | 35 to 45 mm Hg | 41 to 57 mm Hg (higher) |
| Partial pressure of oxygen | Greater than 88 mm Hg (slide 14; slides 23 and 54: greater than 80) | 30 to 40 mm Hg (far lower) |
| pH | 7.35 to 7.45 | 7.31 to 7.41 (lower) |
| Oxygen content | 15 to 22 vol% (mL/dL) | 11 to 16 vol% (lower) |
Why a venous sample can mislead. Venous blood gives information localized to the phlebotomy site and can be affected by temperature, perfusion, movement and local infection; arterial blood is a better mixture.
Venous against arterial, side by side. Venous carbon dioxide pressure is 41 to 57 mm Hg against arterial 35 to 45, and venous pH is 7.31 to 7.41 against arterial 7.35 to 7.45: the venous sample has a higher carbon dioxide pressure and a lower pH.
So a venous carbon dioxide of 50 mm Hg is normal for venous blood even though it would be high for an arterial sample: read each value against the range for its own sample.
The arterial sample
- ★ The radial artery is usually the site of choice. First check the collateral blood supply via the ulnar and radial arteries (the Allen test). The femoral and brachial arteries can also be used.
- The sample can be taken from an arterial line or from a direct arterial stick. The artery must have collateral blood flow, must be superficial and easily accessible, and its surrounding tissues must be relatively non-sensitive.

The procedure in outline (the full procedure is taught in the Clinical Procedures and Surgical Skills course):
- The patient should be sitting or supine.
- Check for collateral circulation; if it is not present, another location must be chosen.
- Palpate the site and ensure the artery has been correctly identified.
- Clean the site and ensure there are no signs of local infection.
- Collect a 3 to 5 mL sample in a pre-heparinized self-filling syringe, remove all air bubbles, place it on ice and send it to the lab. ★ Indicate whether the patient was breathing room air or describe any supplemental oxygen. The sample can only be used for an arterial blood gas if it is less than 3 hours old.
- Hold pressure for a minimum of 2 minutes, or longer as needed until bleeding stops; a pressure dressing may be needed.
19.4 · Objective c — Indications: when to order an arterial blood gas
- To assess oxygenation (the oxygen).
- To assess ventilation (the carbon dioxide).
- To evaluate acid-base status (the pH, bicarbonate and carbon dioxide).
- To monitor response to ongoing therapy, for example whether oxygen therapy is working (the oxygen pressure assesses the efficacy of oxygen therapy).
- To monitor critically ill patients.
- To establish baseline values pre- and post-operatively.
What it cannot tell you. The blood gas indicates how well the lungs are oxygenating blood and whether the heart and circulation are failing, but it does NOT indicate the degree of any abnormality: complete a physical assessment of the patient. ★ Treat the patient and not the labs: do the labs fit the clinical presentation?
How sick, from the numbers alone? The blood gas does NOT indicate the degree of any abnormality; a physical assessment is needed (treat the patient and not the labs).
19.5 · Objective d — Interpreting the blood gas: pH, the steps, what moves each value, compensation
pH ranges from 1 to 14: 7 is neutral; acidity increases as the pH falls below 7, alkalinity as it rises above 7. A very narrow range of pH is compatible with life: 6.9 to 7.8.
- Acidosis: pH less than 7.35. Alkalosis: pH greater than 7.45.
- The body’s acid-base balance is kept within very narrow parameters by buffering systems: primarily the lungs and kidneys, and to a smaller extent the bones and blood.
- The types of derangement: respiratory acidosis, respiratory alkalosis, metabolic acidosis, metabolic alkalosis and mixed disorders.
The step-wise read
Understanding lab values and their variation from normal is critical to diagnosis. ★ Take a step-wise approach to any acid-base problem:
- What is the pH? Low pH: acidosis. High pH: alkalosis.
- What lab values are outside the normal range? The carbon dioxide next: a primary problem with the carbon dioxide and the lungs is respiratory; a primary problem with nonvolatile acids, bicarbonate and the kidney is metabolic.
- Do the labs fit the clinical presentation of the patient?
The first step. The step-wise approach to any acid-base problem starts with the pH: low is acidosis, high is alkalosis. Then: which values are outside the normal range, and do the labs fit the patient?
| Normal values (the exam supplies them) | |
|---|---|
| pH | 7.35 to 7.45 |
| Partial pressure of carbon dioxide (arterial) | 35 to 45 mm Hg |
| Partial pressure of oxygen (arterial) | Greater than 80 mm Hg (slide 14: greater than 88) |
| Oxygen saturation (arterial) | Greater than 94% |
| Bicarbonate | 22 to 26 mEq/L |
| Carboxyhemoglobin | Less than 2% |
| Potassium | 3.6 to 5.2 mEq/L |
| Sodium | 135 to 148 mEq/L |
| Chloride | 98 to 106 mEq/L |
| Calcium | 8.5 to 10.2 mg/dL (the slide’s mEq/L figure is misprinted) |
| Anion gap | 9 to 15 (varies with the source) |
| Base excess or deficit | Plus or minus 2 mEq/L |
What moves the carbon dioxide
| Carbon dioxide pressure | Usual mechanism | Causes |
|---|---|---|
| Elevated | Carbon dioxide retention secondary to hypoventilation | Obstructive lung disease (emphysema, asthma, chronic bronchitis); impaired function of the respiratory center (anesthesia; drugs such as narcotics and barbiturates; head trauma); decreased respiratory function |
| Low | Hyperventilation | Hypoxia, pulmonary emboli, ★ anxiety, pain, pregnancy |
What moves the oxygen
The oxygen pressure measures dissolved oxygen, is directly influenced by the fraction of inspired oxygen, and is an assessment of the ability to oxygenate.
| Oxygen pressure | Causes |
|---|---|
| Low | Anemia; decreased atmospheric oxygen; cardiac dysfunction (cardiac decompensation); intracardiac shunts; chronic obstructive pulmonary disease and other obstructive or restrictive lung disease; pulmonary edema; pulmonary embolism; hypoventilation secondary to neuromuscular disease; insufficient fraction of inspired oxygen |
| Elevated | Polycythemia; increased fraction of inspired oxygen; hyperventilation |
Compensation
| Primary disorder | Compensated by | How fast | Compensation |
|---|---|---|---|
| Respiratory (the carbon dioxide and the lungs) | The kidney adjusting reabsorption of bicarbonate | Over days | Respiratory acidosis: bicarbonate increases. Respiratory alkalosis: bicarbonate decreases. |
| Metabolic (nonvolatile acids, bicarbonate and the kidney) | Adjusting the ventilatory rate and the carbon dioxide | Over minutes to hours | Metabolic acidosis: carbon dioxide decreases (faster breathing). Metabolic alkalosis: carbon dioxide increases. |
Compensating a respiratory alkalosis. Respiratory disorders are compensated by the kidney adjusting bicarbonate reabsorption over days: respiratory alkalosis compensation is a decrease in bicarbonate.
Reading compensation. The pH tells you which way the primary disorder points; the value that matches it is the primary problem, and the other value moving in the same direction is compensation. Long-standing lung disease with a high carbon dioxide, a low pH and a risen bicarbonate is chronic respiratory acidosis with metabolic compensation; prolonged vomiting with a high pH, a high bicarbonate and a raised carbon dioxide is metabolic alkalosis with respiratory compensation. In the metabolic disorders every arrow points the same way (slide 53: acidosis, pH, bicarbonate and carbon dioxide all down; alkalosis, all up); in the respiratory disorders the pH and the carbon dioxide move in opposite directions.
19.6 · Objective e — Expected findings in the four disorders
| Disorder | pH | Carbon dioxide | Bicarbonate | Causes |
|---|---|---|---|---|
| Respiratory acidosis, acute | Below 7.35 | High | Normal | Respiratory depression: drugs such as opioids, barbiturates and anesthetics |
| Respiratory acidosis, chronic | Tries to normalize | High | Rises (metabolic compensation) | Long-standing lung or chest wall disease |
| Respiratory alkalosis | Above 7.45 | Low | Normal | See the list below |
| Metabolic acidosis | Below 7.35 | Normal (compensation lowers it) | Decreased | Acid gain or loss of base |
| Metabolic alkalosis | Above 7.45 | Normal (compensation raises it) | Increased | Base gain, acid loss, potassium or chloride depletion |
★ The four primary conditions: respiratory acidosis, carbon dioxide up with a low pH; respiratory alkalosis, carbon dioxide down with a high pH; metabolic acidosis, bicarbonate down with a low pH; metabolic alkalosis, bicarbonate up with a high pH.
Causes of respiratory acidosis
- Chest wall dysfunction: thoracic cage deformities, kyphoscoliosis.
- Airway obstruction: extrathoracic tumors, asthma, bronchitis, emphysema.
- Circulatory disorders: congestive heart failure, shock.
- Acute: respiratory depression from drugs (opioids, barbiturates, anesthetics).
Causes of respiratory alkalosis
- Depletion of carbon dioxide, most commonly from hyperventilation.
- Stimulation of the brainstem respiratory center: emotional states (excitement, anxiety), fever, pregnancy.
- Salicylates and sepsis: both may cause a mixed respiratory alkalosis and metabolic acidosis.
- Cardiac disease: mild congestive heart failure leads to pulmonary edema (tachypnea); severe congestive heart failure results in hypoperfusion, then lactic acidosis, then metabolic acidosis.
- Mechanical over-ventilation.
Causes of metabolic acidosis
- Acid gain: renal failure, ★ diabetic ketoacidosis, lactic acidosis, anaerobic metabolism.
- Loss of base: diarrhea, renal tubular acidosis.
Causes of metabolic alkalosis
- Base gain: excessive bicarbonate administration.
- Acid loss: vomiting; loss of gastric acids (nasogastric tube suction).
- Potassium depletion and chloride depletion.
Acid-base disorders and potassium
★ pH changes cause changes in serum potassium concentration. In acidosis, potassium shifts into the extracellular space: hyperkalemia. In alkalosis, potassium shifts into the intracellular space: hypokalemia.
Potassium in acidosis and in alkalosis. pH changes cause changes in serum potassium: in acidosis, potassium shifts into the extracellular space, causing hyperkalemia. In alkalosis potassium shifts into the intracellular space, causing hypokalemia.
19.7 · Objective f — Calculating the anion gap
The anion gap is the concentration of anions other than chloride and bicarbonate. Serum albumin accounts for most of the physiologic (normal) anion gap; lactate, ketones, phosphate, sulfate and other organic anions also contribute.
★ Anion gap = sodium − (chloride + bicarbonate). Normal anion gap: 9 to 15 (as with any “normal”, it varies with the source; a range is given when a gap must be interpreted). Potassium is not in the formula.
An anion gap with the potassium given. Anion gap = sodium minus (chloride plus bicarbonate) = 136 minus (99 plus 19) = 136 minus 118 = 18; the potassium is not in the formula.
Worked the right way: sodium 141, chloride 103, bicarbonate 25 (all mEq/L): chloride plus bicarbonate is 128, and 141 minus 128 is a gap of 13, inside 9 to 15. The usual slips are to forget the bicarbonate (141 minus 103 = 38), to add it instead of subtracting it, or to bring in the potassium.
Two anion gaps worked. Anion gap = sodium minus (chloride plus bicarbonate) = 140 minus (104 plus 24) = 140 minus 128 = 12, inside the normal 9 to 15. Anion gap = sodium minus (chloride plus bicarbonate) = 138 minus (112 plus 16) = 138 minus 128 = 10, inside the normal 9 to 15; the potassium is not in the formula.
19.8 · Objective g — The clinical significance of an abnormal anion gap
| Gap | Usually due to | Less often, or also |
|---|---|---|
| Elevated | An increase in unmeasured anions: for example anionic proteins (albumin), ketoacids, phosphate, lactate | A decrease in unmeasured cations: for example calcium, magnesium, potassium, gamma-globulins |
| Decreased | An increase in unmeasured cations: for example lithium | Hypoalbuminemia (the gap must be corrected if albumin levels are abnormal); severe hyperlipidemia, which affects the estimates of sodium and chloride |
Correcting for albumin: add 2.5 mmol/L to the gap for each 1 g/dL of serum albumin below 4.5 g/dL. A low albumin therefore hides part of the gap, and the correction moves it up.
A low gap with a low albumin. A decreased anion gap can be associated with hypoalbuminemia; the gap must be corrected if albumin is abnormal, adding 2.5 mmol/L for each 1 g/dL of albumin below 4.5 g/dL.
So an elevated gap in diabetic ketoacidosis or lactic acidosis reflects the extra unmeasured anions (the ketoacids, the lactate); a low gap sends you to the albumin, to lithium, or to a lipid problem with the sodium and chloride measurements.
20 · Point-of-Care Ultrasound and Diagnostic Integration
Jordan Stores, PA-C · 17 November 2026
Instructional Objectives
Topic Outline 20: Point-of-Care Ultrasound and Diagnostic Integration (the calendar’s Lecture #20)
- Distinguish between focused point-of-care ultrasound and comprehensive ultrasonography.
- Discuss the role of point-of-care ultrasound as an adjunct to the history and physical examination.
- Interpret basic point-of-care ultrasound findings by distinguishing normal and abnormal findings.
- Employ established ultrasound terminology to communicate findings effectively.
- Discuss common point-of-care ultrasound applications in:
- Cardiovascular assessment
- Pulmonary assessment
- Abdominal assessment
- Soft tissue assessment
- Integrate laboratory, imaging, and electrocardiographic findings into clinical decision-making.
The one-line frame for the whole lecture. Point-of-care ultrasound (POCUS) is a focused, limited, goal-directed scan done at the bedside and read by the clinician who performs it, to answer one diagnostic question in real time; the comprehensive study is ordered after the evaluation, performed by a sonographer, read by a radiologist, and takes hours to days. To read any image: black is fluid (anechoic), gray is soft tissue (hypoechoic), white is dense (hyperechoic: bone, stones), and the artifacts are clues, not noise. The lung lives on artifacts: A lines (horizontal) are normal, B lines (vertical) are pulmonary edema.
Abbreviations you will meet: POCUS (point-of-care ultrasound), US (ultrasound), EFAST (extended focused assessment with sonography in trauma), BLUE (bilateral lung ultrasound in emergency), RUSH (rapid ultrasound in shock and hypotension), PSLA and PSSA (parasternal long and short axis), IVC (inferior vena cava), RV and LV (right and left ventricle), RA and LA (right and left atrium), DVT (deep vein thrombosis), PTX (pneumothorax), LVOT (left ventricular outflow tract), RUQ and LUQ (right and left upper quadrant), PCF (pericholecystic fluid).
| In the recording | So |
|---|---|
| Point-of-care ultrasound “is an extension of your history and physical exam”, often still needs follow-up imaging, and is “a complement”: “you have to know its limitations.” Said again at the close: “it’s not a replacement … It’s a complement to everything else.” [part 1 8:44–8:58; part 2 54:29–54:39] | Focused against comprehensive, and the bedside scan’s role (20.1, 20.2). |
| Contraindications: an open globe rupture, and “You should not delay any life-saving measures.” [part 1 9:42–10:01] | The few reasons not to scan (20.2). |
| The indicator: “Just know that you should keep it on the left” (the patient’s right); cardiology flips it, “don’t worry too much about that right now.” [part 1 11:38–11:46] | Indicator to the scanner’s left for every non-cardiac scan (20.4). |
| “Mirror artifact is another one that’s very important to know.” Its absence, with the spine sign, means a pleural effusion, and the class was asked about it again later. [part 1 18:42, 21:38–22:19; part 2 18:02–18:46] | Mirror image is normal above the diaphragm; no mirror plus the spine sign is fluid (20.5, 20.7). |
| B lines: “another really important one”, “kind of pathognomonic” for pulmonary edema; “one of the more helpful things that I tend to see on pulmonary ultrasounds.” [part 1 26:34–27:00; part 2 16:36] | Vertical B lines against horizontal A lines (20.5, 20.7). |
| Color Doppler: a “big misconception” that blue means vein and red means artery; blue is flow away from the probe, red toward it, “important to know that distinction.” [part 1 31:23–31:47] | Color is direction, not vessel type (20.5). |
| “Compressibility is a big one when we start talking about DVTs”; an acute clot can be isoechoic, so “what you’re really looking for is to see if it’s compressible.” [part 1 7:36, 15:03; part 2 38:24] | A vein that will not compress holds a thrombus (20.3, 20.9). |
| Subxiphoid is the view for pericardial effusion because effusions are dependent; the class was asked why the trauma scan uses it. [part 2 9:37–9:45, 43:38–43:51] | Subxiphoid = effusion view (20.6, 20.8). |
| Lung probes: the thin linear probe fits between the ribs up high (pneumothorax); the curvilinear probe works better low, for effusion and pneumonia, with more depth. [part 2 13:47–14:27] | Linear up high, curvilinear low (20.7). |
| Severe cellulitis looks like cobblestoning, “pathognomonic for that.” [part 2 33:30–33:42] | Cobblestoning (20.9). |
| “Should know that the right upper quadrant view is Morison’s pouch.” [part 2 41:12–41:29] | Free fluid between liver and kidney (20.8). |
| “That lung point is actually the most specific sign for ruling in a pneumothorax.” [part 2 45:50–45:55] | Lung sliding, the barcode and the lung point (20.5, 20.7). |
Said to be beyond what you need: the probe movements (“I’m not going to go in a whole lot of depth on this … you can read on this a little bit on your own,” part 1 7:25); ring-down and side lobe artifacts (“We’re not gonna spend a whole lot of time on these,” part 1 24:31); M-mode (“won’t spend a long time on this,” part 1 27:51); color Doppler artifacts (part 1 31:49); the BLUE (bilateral lung ultrasound in emergency) decision tree (“a little bit complicated … look through it on your own time … just know that there are these protocols,” part 2 14:48); and the RUSH (rapid ultrasound in shock and hypotension) series (part 2 39:31). The quizzes go light on all of these.
Where the time went (distinct minutes of speech, about 88 in all; a minute can count for two objectives): the terminology (objective d: the machine, frequency, knobs, probes, indicator, echogenicity, planes, artifacts, modes, Doppler) about 23 minutes; abdominal applications (e.iii: gallbladder, inferior vena cava, aorta, the trauma windows) 19; normal against abnormal (c) 16; cardiac (e.i) 14; the two cases (f) 11; pulmonary (e.ii) 10; the role and procedures (b) 7; focused against comprehensive (a) and soft tissue (e.iv) 3 each. The recording starts after the title slide and the first case, so those have no audio.
Said aloud but not on the slides (not asked): measuring an abdominal aortic aneurysm (“You guys might not have all these slides in your copy,” part 2 30:21; the deck has no such slide); that absent lung sliding alone does not prove a pneumothorax (part 2 45:20); that edema and cellulitis look almost the same on ultrasound (part 2 33:45); the fish mouth and chevron valve signs (part 2 8:03, 8:17).
Where the slide and the recording differ. No slide was corrected aloud. (1) Slide 19 says the effusion fluid amplifies the sound; aloud it was “enhance transmission” (part 1 22:13), which is the better physics (see the note in 20.7). (2) The slides call the parasternal long axis often the easiest view to obtain and the apical four chamber sometimes difficult; aloud the apical four chamber was “the most easily intuitive view to understand” for new learners (part 2 2:50) and “a little bit challenging to obtain” (part 2 12:27). Easy to understand is not easy to obtain; the slides are keyed. (3) The stable leg-swelling case: aloud, a bedside scan is “not wrong” but will not change immediate management, and a formal study is still needed (part 2 53:43–54:20), which agrees with slide 65.
20.1 · Objective a — Focused point-of-care ultrasound against comprehensive ultrasonography
| Point-of-care ultrasound | Traditional (comprehensive) ultrasound |
|---|---|
| Used at the bedside to give real-time answers to diagnostic questions | Ordered after evaluating the patient |
| Focused, limited, goal directed | Comprehensive, but takes time: hours to days |
| Interpreted by the provider performing it | Performed by a certified sonographer, interpreted by a radiologist |
| Can be an extension of the history and physical exam, often when the patient may not be able to give enough information | |
| May often still need formal imaging to follow; a complement to the other workup |

When the bedside scan is not the answer. A stable patient with a likely deep vein thrombosis (leg pain and swelling after knee replacement, no chest pain or shortness of breath, normal vital signs) “needs formal US, probably not POCUS in this case”. Point-of-care scanning earns its place when the question cannot wait, as in the patient in sudden, undifferentiated respiratory distress (20.10). Slides 64 and 65.
20.2 · Objective b — Its role beside the history and physical examination: indications, contraindications, procedures
Point-of-care ultrasound is an extension of the history and physical examination, used at the bedside for real-time answers, and a complement to the rest of the workup (20.1).
| When and where it is indicated | When it is contraindicated (“not very often!”) |
|---|---|
| Trauma · Cardiac · Pulmonary · Vasculature · Ophthalmic · Renal · Gallbladder · Appendix · Scrotal · Obstetric/gynecologic | Globe rupture Should not delay lifesaving measures Some anatomical locations are not amenable to ultrasound |
Contraindications, in a sentence. Point-of-care ultrasound is not often contraindicated, but globe rupture is one of the listed contraindications. The others: it should not delay lifesaving measures, and some anatomical locations are not amenable to ultrasound.
Indications, in a sentence. The listed point-of-care indications are trauma, cardiac, pulmonary, vasculature, ophthalmic, renal, gallbladder, appendix, scrotal and obstetric/gynecologic.
Common applications: cardiac, pulmonary, abdominal, soft tissue and vascular scanning; protocol-based scans (EFAST, RUSH, BLUE; 20.8, 20.7); and procedural guidance: central venous catheter insertion, paracentesis, thoracentesis. Vascular uses: central lines, ultrasound-guided IVs and DVTs.
Procedural uses. Procedural point-of-care ultrasound includes central venous catheter insertion, paracentesis and thoracentesis, and vascular uses include central lines and ultrasound-guided intravenous access.
Artery or vein? In general, arteries are pulsatile if compressed and have minimal compressibility; veins are completely compressible (unless filled with clot). This identifies structures, especially for vascular procedures. Slide 46.
20.3 · Objective c — Normal against abnormal: the findings at a glance
Every abnormal finding below is taught with its image in the application sections (20.6 to 20.9). The table is the one-page comparison.
| Where | Normal | Abnormal |
|---|---|---|
| Lung surface | A lines (horizontal repeats of the pleural line); lung sliding; M-mode “seashore” (“ocean” above the pleural line, “sand on the beach” below) | B lines (vertical) = pulmonary edema; M-mode barcode = pneumothorax; a lung point rules in pneumothorax |
| Above the diaphragm | Air is an acoustic barrier: the liver is mirrored (mirror image artifact) | Absence of mirroring and the spine sign = pleural effusion |
| Lung tissue | Aerated lung shows only artifacts | Pneumonia: bronchograms, B lines, hepatization (lung looks like liver), effusion or empyema, spine sign |
| Gallbladder | Thin-walled, anechoic | Stone with a posterior acoustic shadow, wall thickening, pericholecystic fluid; plus a sonographic Murphy sign = cholecystitis |
| Liver–kidney (Morison’s pouch), spleen, pelvis | Organs against each other, no dark stripe | A dark (anechoic) stripe = free fluid |
| Veins | Completely compressible | Not compressible = thrombus (DVT); content hypo- or hyperechoic with chronicity; may lose color flow |
| Soft tissue | Orderly layers | Cellulitis: distortion, cobblestoning; abscess: anechoic/hypoechoic collection, pus shifts with compression |
| Inferior vena cava | Collapse of more than 50% with inspiration = dehydration or fluid responsiveness |

20.4 · Objective d — Terminology I: the machine, the probe, orientation and echogenicity
| Term | What it means |
|---|---|
| Ultrasound | Sound above what human ears can hear (more than 20,000 hertz) used to create an image |
| Piezoelectric crystals | Tiny crystals in the probe: a current makes them vibrate and send a sound wave; the returning echo vibrates them again, and that is converted to electricity, which the computer turns into a real-time image |
| Frequency | How often sound waves are emitted. Higher frequency: better resolution, less depth. Lower frequency: better depth, less resolution. Short wavelength = high frequency |
| Depth | How far you are zoomed in |
| Gain | Brightness |
| Transducer selection | Different probes suit different sites: phased array, linear, curvilinear, endocavitary |
| Transducer movements | Fan, rock, sweep, slide, rotate, compress |
| Indicator (probe marker, orientation marker) | Orients you to the image. Keep it pointed to your left (the patient’s right); cardiology puts it opposite. It should match the orientation marker on the screen |
| Planes | Transverse (axial): indicator to your left, look through the patient; sagittal (longitudinal); coronal (frontal) |




Echogenicity: how bright a tissue appears compared to another
| Term | Looks | Because | Examples |
|---|---|---|---|
| Anechoic | Black | Does not echo sound waves back | Fluid-filled structures |
| Hypoechoic | Gray | Returns less echo than surrounding structures | Liver, spleen |
| Hyperechoic | White | Dense; returns more echoes than surrounding structures | Bone, stones |
| Isoechoic | Same as its surroundings | Same density as surrounding structures |

20.5 · Objective d — Terminology II: artifacts, modes and color Doppler
| Artifact | What happens | Look for |
|---|---|---|
| Acoustic shadowing | Happens with hyperechoic structures; air can shadow too, “dirtier” than shadowing from bone | A dark band behind ribs or stones |
| Posterior acoustic enhancement | Sound through a fluid-filled structure enhances the images deep to it, making them bright; it can obscure them | Bright area behind the bladder or gallbladder |
| Edge artifact | A refraction artifact: sound waves “bend” off the edge of a fluid-filled structure | A dark line off the curved edge |
| Mirror image artifact | A reverberation artifact: sound hits a strong reflector, and the image is mirrored on the other side of it | Liver copied above the diaphragm (normal) |
| Ring down artifact | Caused by foci of air | Bright streaks, as with hepatic pneumobilia |
| Side lobe artifact | Sound reflected by a strong reflector outside the central beam appears as if it is in it | Echoes inside the gallbladder lumen |
| A lines (reverberation) | Horizontal repeats of the pleural line | The normal lung |
| Comet tails (reverberation) | Vertical hyperechoic lines; may come off calcifications, cholesterol, metal | Short bright tails off the gallbladder wall |
| B lines (reverberation) | Vertical hyperechoic lines in the lung from an air-water interface | Pulmonary edema |








Modes and color Doppler
| Mode | What it shows |
|---|---|
| B-mode (brightness) | The standard view: shades of gray producing a two-dimensional image |
| M-mode (motion) | One line of the B-mode image showing movement over time; common uses are fetal ultrasound and pneumothorax |
| Color Doppler | Direction and velocity, represented by color. BART: Blue Away, Red Towards; perpendicular = black. Blue and red do not necessarily mean venous and arterial. It has its own artifacts (twinkle artifact, aliasing) |



20.6 · Objective e.i — Cardiovascular assessment: the four windows
Cardiac scanning uses the phased array (cardiac) probe and four main viewing windows.
| Window | How | What it is for |
|---|---|---|
| Parasternal long axis | Beside the sternum; the heart laid out lengthwise (RV on top, LV, aorta, LA) | Often the easiest view to obtain |
| Parasternal short axis | Rotate the probe 90 degrees so the marker is toward the patient’s right hip | Cross-section of the ventricles; good view of the mitral and aortic valves |
| Subxiphoid (subcostal) | Probe under the xiphoid, just to the patient’s right of midline; uses the liver as a window | Best view for pericardial effusion, since most effusions are inferior |
| Apical four chamber | At the apex; sometimes difficult to obtain | All four chambers at once; important for RV dilation or strain. Rotate for a five chamber view that adds the aortic valve/LVOT |







Slides 32 and 33 (a parasternal long axis clip and two ejection-fraction clips) carry no slide text, and slide 18 (“Mirroring artifact on cardiac pocus”) is a video kept outside the deck; neither is taught here.
20.7 · Objective e.ii — Pulmonary assessment
| Probe | Better for |
|---|---|
| Linear | Pneumothorax |
| Curvilinear | Pleural effusion, pulmonary edema, pneumonia |
Multiple anterior and posterior views are available. The BLUE protocol (bilateral lung ultrasound in emergency) and others exist.


| Condition | What the slides show |
|---|---|
| Pulmonary edema | B lines: vertical hyperechoic lines from an air-water interface |
| Pleural effusion | Dark fluid above the diaphragm; absence of mirroring: normally air is an acoustic barrier, but with an effusion the fluid amplifies the sound waves and the thoracic vertebrae are seen through the acoustic window (spine sign) (Note: strictly, fluid does not amplify sound; it transmits it well without reflecting it, which is why the spine shows through. The slide’s wording is what the exam keys.) |
| Pneumonia | Bronchograms (air/fluid/consolidations in bronchi); B lines; hepatization (lung looks like liver); pleural effusions or empyema; spine sign |
| Pneumothorax | M-mode barcode (not the seashore, 20.5); a lung point (with abolished sliding and an A′-profile, BLUE leads to pneumothorax) |




Lung sliding itself is shown only as moving clips (slide 38 is a single still; the right half of slide 39 and the pneumonia clip on slide 42 are videos kept outside the deck), so it is taught here through the BLUE tree and M-mode.
20.8 · Objective e.iii — Abdominal assessment: gallbladder, inferior vena cava, aorta and the protocols
Abdominal point-of-care targets: the gallbladder, the inferior vena cava, the aorta and many others.
Cholecystitis on ultrasound: a stone (with a posterior acoustic shadow), wall thickening and pericholecystic fluid, “plus sonographic murphy sign are signs of cholecystitis”.

| Target | What the slides say |
|---|---|
| Inferior vena cava | Helps determine volume status and fluid responsiveness. Collapse of more than 50% with inspiration indicates dehydration or fluid responsiveness. Probe placed longitudinal just right of midline |
| Aorta | Arteries are pulsatile with minimal compressibility; veins are completely compressible unless filled with clot |


Protocols: several views combined for one scenario
| Protocol | Scenario |
|---|---|
| FAST/EFAST (focused assessment with sonography in trauma; extended) | Trauma |
| BLUE (bilateral lung ultrasound in emergency) | Lungs |
| RUSH (rapid ultrasound in shock and hypotension) | Shock/hypotension |
| EFAST window | Looks for |
|---|---|
| 1 · Right upper quadrant | Peritoneal and pleural free fluid |
| 2 · Left upper quadrant | Peritoneal and pleural free fluid |
| 3 · Suprapubic | Peritoneal free fluid |
| 4 · Subxiphoid / parasternal | Pericardial effusion |
| 5, 6 · Right and left anterior chest | Pneumothorax |




20.9 · Objective e.iv — Soft tissue assessment, and the veins
| Finding | Ultrasound |
|---|---|
| Cellulitis | Distortion of soft tissue; cobblestoning |
| Abscess | Anechoic/hypoechoic collection (can vary a lot); pus will shift with compressing |
| Deep vein thrombosis | Assess for compressibility: thrombus will not be compressible, the major diagnostic feature. Hypoechoic or hyperechoic content may be seen depending on chronicity. May have loss of color flow |


20.10 · Objective f — Integrating the findings into the decision
The deck integrates the bedside scan with the history, the examination and the vital signs; it shows no laboratory values and no electrocardiogram, so nothing here goes beyond that. Its two cases set the principle:
| The patient | The bedside reasoning |
|---|---|
| Sudden, undifferentiated respiratory distress in a patient with very high blood pressure, then diffuse crackles and dyspnea without chest pain | An unstable, undifferentiated patient needs a bedside answer now; diffuse B lines with crackles and the blood pressure point to flash pulmonary edema (the slide’s answer: “Flash pulmonary edema/SCAPE”, SCAPE being sympathetic crashing acute pulmonary edema; she improved on BiPAP (bilevel positive airway pressure) and a nitroglycerin drip) |
| Stable leg pain and swelling after knee replacement, no chest pain or shortness of breath, normal vital signs | “Likely DVT, but stable”: formal ultrasound, probably not point-of-care (Note: current practice also accepts a point-of-care compression ultrasound for a suspected deep vein thrombosis in trained hands; the slide’s answer, formal ultrasound, is what the exam keys.) |
The protocols are integration built in: EFAST answers the trauma questions (free fluid, pericardial effusion, pneumothorax) in one pass; the inferior vena cava answers the volume question in a hypotensive patient; BLUE sorts acute dyspnea into edema, embolism, pneumonia, pneumothorax and obstructive disease.
21 · Transfusion Medicine and Blood Banking Fundamentals
Professor Reynolds · 19 November 2026
Instructional Objectives
Topic Outline 21: Transfusion Medicine and Blood Banking Fundamentals
- Define the importance of pre-transfusion testing.
- Compare and contrast ABO blood groups and compatibility.
- Review Rh factor and incompatibility.
- Discuss laboratory testing used in transfusion medicine.
- Describe laboratory findings associated with transfusion reactions.
- Acute hemolytic transfusion reactions
- Delayed hemolytic transfusion reactions
- Febrile non-hemolytic transfusion reactions
- Allergic transfusion reactions
- Anaphylactic transfusion reactions
The one-line frame for the whole lecture. Human error at the bedside, not the laboratory, drives fatal reactions, so identification comes first. ABO antibodies are naturally occurring IgM that lyse cells inside the circulation within minutes; Rh antibodies are acquired IgG that clear cells in the spleen, gradually. Red cell and plasma compatibility run in opposite directions (O is the universal red cell donor, AB the universal plasma donor). The testing sequence is type and screen (ABO, Rh, unexpected antibodies) then crossmatch; the direct antiglobulin test separates the hemolytic reactions (positive) from the non-hemolytic ones (negative).
Abbreviations you will see on the slides and in orders: DAT (direct antiglobulin test, direct Coombs), IAT (indirect antiglobulin test, indirect Coombs), AHG (antihuman globulin, Coombs serum), T&S (type and screen), T&C (type and crossmatch), IS (immediate-spin crossmatch), HDFN (hemolytic disease of the fetus and newborn), RhIG (Rh immune globulin, RhoGAM), AHTR (acute hemolytic transfusion reaction), DHTR (delayed hemolytic transfusion reaction), FNHTR (febrile non-hemolytic transfusion reaction), LDH (lactate dehydrogenase), DIC (disseminated intravascular coagulation), ATN (acute tubular necrosis), MRN (medical record number), FFP (fresh frozen plasma), MTP (massive transfusion protocol).
| In the recording | So |
|---|---|
| Her frame: “this is not pathophys, this is diagnostics.” [0:17–0:21] | The tests and how to read them carry the lecture (21.8–21.12, 21.19). |
| The second-sample rule: “It’s that important.” [0:04] And at the end: human error “is the thing that oftentimes drives when people don’t do well.” [49:13–49:24] | Bedside identification and the second sample (21.1). |
| “Here is a very important table for you.” Then: “O can give everybody red cells but they can only receive red cells from other O. But they can get plasma from everybody. And then opposite is true for AB.” [2:05; 10:50–11:25] | The compatibility matrix and the inverse rule (21.3). |
| O-positive for “any adult male and any older female not of childbearing age”; O-negative saved for “females of childbearing age.” [13:20–14:09] | Emergency release (21.4). |
| IgM “is too big” to cross the placenta; “IgG is smaller, and it can, and so that’s why this is an issue.” [20:28–21:26] | Why Rh, not ABO, is the classic cause of hemolytic disease of the fetus and newborn on these slides (21.6, 21.7). |
| Forward and reverse typing “have to be essentially mirrors of each other … antigens on the cell, antibodies in the plasma.” [24:09–25:23] | Read both halves; they must agree (21.8). |
| Extra antibody work after repeated transfusions “can take like an hour or more.” [27:42–28:22] | A positive screen costs time: order early (21.9). |
| The 3-day rule: “in about 72 hours, we might have new antibodies present.” [31:00–32:37] | 21.12 (see the note there on how she stated it). |
| “In any suspected reaction, here’s an always … always stop the blood. Rarely, you will restart it.” [50:53–51:11; also 32:44–32:52] | Step 1 of the protocol (21.13). |
| Urticaria: “This is the only one where you would potentially restart the transfusion.” [39:49–40:43] | The restart rule (21.17). |
| Fever (acute hemolytic and febrile) and a positive direct antibody test (acute and delayed hemolytic) “really help you kind of narrow down what the problem is.” The direct test is “your key marker, lab marker to determine hemolytic versus non-hemolytic.” [42:14–42:47; 50:09–50:40] | The two columns that sort the five reactions (21.19). |
| The delayed hemolytic reaction: “this is the one where you primary care people aren’t able to escape”; “often diagnosed outpatient … keep that on your differential.” [47:07; 48:57–49:07] | Days later, jaundice and a falling hemoglobin (21.15). |
Less weight: the sickle cell mimicry “is pathophys … beyond labs” [36:52–37:03]; platelet compatibility rules “don’t necessarily apply the same way” [6:29]; pediatric rules she did not cover [14:20]. She worked four cases aloud for the empty Cases slide [42:55–49:07]; they are not on the slides, so nothing is built from them.
21.1 · Objective a — Why pre-transfusion testing matters: human error at the bedside
The clinical anchor case. A trauma patient in bay 1 receives a unit intended for bay 2 because of bedside misidentification. Within 5 minutes the patient develops rigors, severe flank pain, tachypnea, acute hypotension and dark port-wine urine. The root cause is a mislabeled sample (“wrong blood in tube”) or a failure of bedside two-person verification. Takeaway: fatal ABO incompatibility is almost universally clerical — the blood bank testing was accurate, but the blood was delivered to the wrong patient.
| Core safety protocol | What it requires |
|---|---|
| Bedside sample labeling | Label immediately at the bedside in front of the patient; never pre-label tubes or label away from the patient. |
| Two-identifier verification | Match the patient name, medical record number (MRN), unit blood type and unit serial number directly against the wristband. |
| The critical first 15 minutes | Infuse the first 25–50 mL slowly; severe acute hemolytic reactions manifest rapidly, after as little as 25 mL. |
| The second-sample rule | If the patient has no prior verified blood type on record, a second separate sample must be drawn and tested to confirm the ABO/Rh type. |
Cardinal rule 1 — human error drives mortality. Most fatal hemolytic reactions stem from bedside clerical errors, not laboratory testing. Verify patient identity and blood unit at the bedside.
21.2 · Objective b — ABO: carbohydrate antigens and naturally occurring IgM
| Carbohydrate antigens | Natural IgM antibodies | The intravascular cascade |
|---|---|---|
| A and B antigens are oligosaccharides (terminal sugars) attached to cell membrane glycoproteins. Group O expresses only the unmodified H antigen core structure (no A or B sugars). Group A possesses N-acetylgalactosamine transferase. Group B possesses D-galactosyltransferase. Group AB expresses both A and B antigens simultaneously. |
Naturally occurring: individuals consistently form antibodies against the ABO antigens they lack, without prior transfusion. Environmental priming: triggered during infancy by cross-reactive gut flora and food carbohydrates. IgM dominance: a large pentameric structure, highly efficient at fixing complement (C1q binding). The rule: you always produce antibodies against the ABO antigens absent from your own red blood cells. |
Complement activation: full assembly of the membrane attack complex (C5b-9) directly in the circulation. Immediate lysis: red cell rupture releases free hemoglobin into the plasma (hemoglobinemia). Vasoactive storm: the anaphylatoxins C3a and C5a cause systemic vasodilation, hypotension and shock. Renal and hemostatic crisis: free hemoglobin causes tubular precipitation / acute tubular necrosis; microvascular procoagulants trigger disseminated intravascular coagulation. |
The slide spells the rule “Landeiner’s Rule”; the standard name is Landsteiner’s rule.
21.3 · Objective b — Compatibility: red cell and plasma rules run in opposite directions
| Blood group | Red cell antigens | Plasma antibodies | Can receive red cells from | Can receive plasma from |
|---|---|---|---|---|
| O | None (H antigen) | Anti-A and anti-B | O only | O, A, B, AB (universal) |
| A | A antigen | Anti-B | A, O | A, AB |
| B | B antigen | Anti-A | B, O | B, AB |
| AB | A and B antigens | None | AB, A, B, O (universal) | AB only |
The inverse compatibility rule. Red cell transfusions: group O is the universal red cell donor (no ABO antigens to react with recipient antibodies); group AB is the universal red cell recipient. Plasma transfusions: group AB is the universal plasma donor (its plasma lacks anti-A and anti-B); group O is the universal plasma recipient.
21.4 · Objective b — Emergency release: O-negative against O-positive in massive hemorrhage
| O-negative: the scarce universal red cell | O-positive: protocol stewardship |
|---|---|
| Only about 6–7% of the US population is O-negative. A strict emergency reserve: mandatory for females of childbearing potential (<50 years old) with an unknown blood type in acute trauma. Preventing alloimmunization: inadvertent RhD exposure in young females risks lifelong anti-D formation and fetal hydrops in future pregnancies. Emergency release: sent uncrossmatched while the blood bank proceeds with rapid confirmatory testing. |
About 37–39% of the population is O-positive. Massive transfusion protocol standard: used for adult males and post-menopausal females. No hemolytic collapse: an Rh-negative male given O-positive red cells will NOT suffer immediate acute intravascular hemolysis. Calculated risk: alloimmunization (anti-D formation) may occur, but survival of acute hemorrhagic shock takes clinical precedence. |
21.5 · Objective c — The RhD antigen: a protein that needs prior exposure
| RhD protein immunogenicity | No natural antibodies | Extravascular clearance |
|---|---|---|
| Unlike the ABO carbohydrates, RhD is a transmembrane structural protein. High potency: the most immunogenic red cell antigen outside the ABO system. Terminology: “Rh-positive” strictly denotes the presence of the RhD polypeptide; “Rh-negative” denotes its absence. Distribution: about 85% of Caucasians and more than 90% of African Americans and Asians are RhD-positive. |
Sensitization required: Rh-negative individuals have ZERO pre-existing anti-D at baseline. Exposure: transfusion of Rh-positive red cells or feto-maternal hemorrhage during pregnancy or delivery. Anti-D is monomeric IgG (predominantly IgG1 and IgG3). Delayed production: weeks to months for the primary IgM-to-IgG response to mature. |
IgG-coated red cells are recognized by splenic Fc-gamma receptors. Opsonized cells are destroyed by macrophages in the reticuloendothelial system. Gradual course: spherocyte formation, mild hyperbilirubinemia, low haptoglobin. Absence of shock: rarely triggers acute complement-mediated intravascular collapse or disseminated intravascular coagulation. |
21.6 · Objective c — Rh incompatibility: hemolytic disease of the fetus and newborn, and Rh immune globulin
| Pathophysiology of hemolytic disease of the fetus and newborn | The Rh immune globulin (RhoGAM) protocol |
|---|---|
| Sensitization: an RhD-negative mother carries an RhD-positive fetus; transplacental feto-maternal hemorrhage occurs during delivery or trauma. Maternal alloimmunization: she mounts an immune response, producing high-affinity IgG anti-D. Subsequent pregnancies: maternal IgG readily crosses the placenta via syncytiotrophoblast Fc receptors into the fetal circulation. Fetal destruction: anti-D binds fetal red cells → splenic destruction → profound anemia, extramedullary hematopoiesis, high-output heart failure (hydrops fetalis). |
Mechanism: the given anti-D binds and masks fetal D-positive cells, clearing them before the maternal B cells mount an immune response. Routine prophylaxis: at about 28 weeks of gestation to all non-sensitized RhD-negative mothers. Post-partum dose: within 72 hours of delivering an RhD-positive neonate. Potentially sensitizing events: must be given after miscarriage, ectopic pregnancy, abortion, amniocentesis or abdominal trauma. Kleihauer-Betke test: quantifies the volume of fetal-maternal hemorrhage to calculate whether additional vials of Rh immune globulin are required. |
Beyond the slides: anti-D is the IgG the deck teaches crossing the placenta; IgG anti-A and anti-B can also cross and cause ABO hemolytic disease of the newborn. The deck does not test this.
21.7 · Objective c — ABO against RhD, head to head
| Feature | ABO blood group system | Rh (D) antigen system |
|---|---|---|
| Antigen chemistry | Carbohydrate oligosaccharides (A, B, H) | Transmembrane polypeptide protein (D) |
| Baseline antibodies | Naturally occurring (present without exposure) | Absent until sensitized by transfusion or pregnancy |
| Predominant antibody class | IgM (pentamer, avid complement activator) | IgG (monomer, crosses the placenta) |
| Primary hemolysis site | Intravascular (direct circulating cell lysis) | Extravascular (splenic reticuloendothelial system) |
| Clinical reaction severity | Acute, dramatic: shock, acute disseminated intravascular coagulation, acute tubular necrosis | Gradual: asymptomatic drop in hemoglobin, mild jaundice |
Cardinal rule 2 — ABO and Rh operate under distinct rules. ABO antibodies are naturally occurring IgM that cause rapid intravascular lysis. Rh antibodies are acquired IgG causing extravascular clearance.
21.8 · Objective d — ABO typing: forward and reverse must agree
| Forward (front) typing: detects ANTIGENS | Reverse (back) typing: detects ANTIBODIES | |
|---|---|---|
| Sample | The patient’s red blood cells (washed suspension) | The patient’s plasma or serum |
| Reagents | Commercial monoclonal anti-A and anti-B antisera | Known commercial reagent red cells (A1 cells and B cells) |
| Mechanism | Direct agglutination testing | Detects the expected reciprocal isohemagglutinins |
| Forward typing result | Reads as | Reverse typing result | Reads as |
|---|---|---|---|
| Agglutination with anti-A | A antigen present | Agglutination of B cells only | Anti-B present (group A) |
| Agglutination with anti-B | B antigen present | Agglutination of A1 cells only | Anti-A present (group B) |
| Agglutination with anti-D | Rh(D) positive | Agglutination of both A1 and B cells | Group O |
| No agglutination with anti-A or anti-B | Group O | No agglutination of either cell | Group AB |
ABO discrepancy rule. Forward and reverse types MUST match before blood is released. Any discrepancy prompts immediate investigation.
21.9 · Objective d — The antibody screen (an indirect antiglobulin test) and antibody identification
| The antibody screen | Antibody identification and allocation |
|---|---|
| Purpose: identifies unexpected circulating IgG alloantibodies against clinically significant red cell antigens (for example Kell, Duffy, Kidd, Rh C/E). Method: patient plasma is incubated in vitro with 2 to 3 group O reagent red cell vials expressing comprehensive antigen profiles. Antihuman globulin is added to crosslink IgG-sensitized red cells, producing visible agglutination. Negative screen: no unexpected red cell antibodies (about 95–98% of patients). Positive screen: the patient has formed an alloantibody from prior transfusion, transplantation or pregnancy. |
Identification panel: when the screen is positive, an 11- to 16-cell panel is tested to map the antibody’s specificity. High-risk specificities: anti-Kell (anti-K), anti-Kidd (anti-Jka/Jkb), anti-Duffy (anti-Fya), anti-Rh (anti-c, anti-E). Antigen-negative sourcing: the blood bank must phenotypically screen donor units to find and crossmatch red cells lacking that antigen. Clinical consequence: compatible units can take hours or days; order the type and screen well in advance of elective procedures. |
21.10 · Objective d — Crossmatching: the tier depends on the screen and the antibody history
| Electronic / computer | Immediate-spin | Full antiglobulin (antihuman globulin) | |
|---|---|---|---|
| Requirement | Negative antibody screen AND at least two concordant blood type records on file | Negative antibody screen with no history of clinically significant alloantibodies | Positive antibody screen OR documented history of clinically significant antibodies |
| Mechanism | Validated laboratory software verifies ABO/Rh compatibility between donor unit and recipient | Recipient serum mixed with donor red cells at room temperature and centrifuged immediately | 37 °C incubation, then antihuman globulin (Coombs serum) is added |
| Purpose | Extremely rapid unit allocation; no technician pipetting steps | Final serologic check to confirm ABO compatibility and rule out a clerical mismatch | Detects weak IgG binding against specific minor red cell antigens |
| Turnaround | Instantaneous (<1 minute) | About 5 to 10 minutes | 45 to 60+ minutes per unit |
21.11 · Objective d — The direct against the indirect antiglobulin test
| Direct antiglobulin test (DAT, direct Coombs) | Indirect antiglobulin test (IAT, indirect Coombs) | |
|---|---|---|
| Core question | “Are the patient’s red blood cells ALREADY coated with antibodies or complement inside the body?” | “Does the patient have FREE, UNBOUND antibodies in the plasma that could attack donor cells?” |
| Clinical context | Workup of acute or delayed hemolytic transfusion reactions, autoimmune hemolytic anemia and hemolytic disease of the fetus and newborn | Pre-transfusion antibody screening, maternal prenatal antibody screens, compatibility crossmatching |
| Specimen | The patient’s washed circulating red blood cells (in vivo attachment) | Patient plasma or serum incubated with known reagent red cells (in vitro attachment) |
| Reagent | Polyspecific antihuman globulin (anti-IgG plus anti-C3d); if positive, tested with monospecific anti-IgG and anti-C3d | Antihuman globulin added after incubation and washing |
| Result | Agglutination = POSITIVE (confirms immune-mediated red cell coating) | Agglutination = POSITIVE (proves a circulating alloantibody) |
21.12 · Objective d — Type and screen against type and crossmatch, and the 3-day specimen rule
| Type and screen | Type and crossmatch | The 3-day specimen rule |
|---|---|---|
| Determines ABO, Rh, and tests plasma for unexpected alloantibodies. Blood allocated: ZERO units assigned or held. Setting: transfusion possible but not immediately expected (routine surgery, a stable gastrointestinal bleed). Advantage: preserves inventory; if transfusion is needed, units can be crossmatched rapidly. |
Completes the type and screen and physically matches donor units to the patient’s serum. Blood allocated: specific numbered units are tagged and RESERVED in the blood bank. Setting: transfusion is planned, highly probable or actively ongoing. Stewardship: held units are unavailable to other patients until explicitly released. |
The sample is valid for only 72 hours (3 days) if the patient was (1) transfused within the prior 3 months, (2) pregnant within the prior 3 months, or (3) has an uncertain clinical history. Rationale: new alloantibodies can form rapidly following secondary exposure. Impact: an expired sample requires an entirely new redraw and repeat testing. |
In the recording the 3-day rule sounded universal (“regardless of what we do, there’s always a three-day specimen rule”, 31:00; “you have to repeat it again in three days, especially if you’ve transfused them”). The slide limits it to the three conditions above; the slide is what is keyed.
Cardinal rule 3 — understand the testing sequence. The type and screen checks the patient’s status; the crossmatch allocates specific donor units. A positive screen requires an antibody panel and a full antihuman globulin crossmatch.
21.13 · Objective e — The universal immediate response to any suspected reaction
| Step | What to do |
|---|---|
| 1. Stop the infusion immediately | Do not slow the rate — halt the transfusion. Disconnect the tubing from the intravenous catheter hub. |
| 2. Maintain intravenous access with saline | Hang fresh normal saline with new tubing. Never flush the remaining blood in the transfusion line into the patient. |
| 3. Clerical recheck at the bedside | Compare the patient’s wristband against the unit label, the bag paperwork and the compatibility slip. |
| 4. Notify the blood bank and attending | The blood bank inspects post-transfusion samples and verifies donor lots. |
| 5. Return the blood bag and tubing | Send the remaining product, the intact tubing and all attached tags back to the blood bank for testing and cultures. |
| 6. Draw post-reaction labs | Fresh blood and urine: repeat ABO/Rh, direct antiglobulin test, complete blood count, metabolic panel, free plasma hemoglobin and urinalysis. |
21.14 · Objective e.i — Acute hemolytic transfusion reaction: intravascular collapse
| Pathophysiology and presentation | Laboratory fingerprint and management |
|---|---|
| Cause: ABO incompatibility (90%+ clerical error) triggering IgM complement-mediated intravascular lysis. Timing: rapid onset, within minutes of starting (as little as 25 mL can be fatal). Classic triad: (1) high fever and rigors; (2) flank or lower back pain (renal vasoconstriction); (3) red or dark urine (hemoglobinuria). Severe progression: sense of impending doom, dyspnea, hypotension and shock, acute tubular necrosis, and catastrophic disseminated intravascular coagulation with bleeding from intravenous sites. |
Direct antiglobulin test: newly positive (anti-A or anti-B coating the remaining cells); it may be negative if all donor cells are instantly lysed. Plasma and urine: pink or red plasma (hemoglobinemia) and red urine (hemoglobinuria). Hemolysis profile: undetectable haptoglobin, markedly elevated LDH (lactate dehydrogenase), then a rise in indirect bilirubin. Coagulation: disseminated intravascular coagulation labs: prolonged prothrombin time (and INR) and partial thromboplastin time, elevated D-dimer, decreased fibrinogen and platelets. Renal: rising urea nitrogen and serum creatinine; hyperkalemia. Management: aggressive intravenous hydration (target urine output 100–200 mL/hr), vasopressors for shock, maintain renal perfusion. |
In the recording, red urine was explained as bilirubin in the urine (35:03); the slide calls the red or dark urine hemoglobinuria, and the slide is what is keyed. She also mentioned irradiated, leukoreduced red cells for vulnerable patients (37:58); that product is not on the slides.
21.15 · Objective e.ii — Delayed hemolytic transfusion reaction: anamnestic IgG clearance
| Pathophysiology and time course | Laboratory findings and the sickle cell danger |
|---|---|
| Mechanism: a secondary (anamnestic) IgG response against minor red cell antigens (Kidd, Rh, Duffy, Kell). Timeline: typically 3 to 30 days after transfusion (peak 5–15 days). The anamnestic trap: the historical antibody was undetectable on the pre-transfusion screen; re-exposure to the donor antigen stimulates rapid IgG production. Clinical features: often indolent or silent; an unexplained drop in hemoglobin (or failure to rise by 1 g/dL per unit), low-grade fever, mild jaundice. Extravascular clearance: red cells phagocytosed by splenic macrophages; hemodynamic collapse is rare. |
Diagnostic labs: a newly positive direct antiglobulin test (IgG coating the transfused cells); a newly positive antibody screen with a new alloantibody identified (for example anti-Jka); elevated LDH (lactate dehydrogenase) and indirect bilirubin, reduced haptoglobin; spherocytes on the peripheral smear. Sickle cell disease alert: a high risk of a delayed reaction mimicking a vaso-occlusive pain crisis; hemoglobin A falls disproportionately. Hyperhemolysis syndrome: antibodies destroy BOTH donor cells AND the patient’s own red cells; reticulocytopenia develops; further transfusions can be fatal. |
21.16 · Objective e.iii — Febrile non-hemolytic transfusion reaction: a diagnosis of exclusion
| Pathogenesis and features | Workup and management |
|---|---|
| Incidence: common (about 1% of transfusions; higher with platelets). Dual cause: (1) cytokines (interleukin-1, interleukin-6, tumor necrosis factor alpha) accumulated in stored plasma; (2) recipient antibodies against donor white blood cell (HLA, human leukocyte antigen) antigens. Definition: a temperature rise of at least 1 °C (1.8 °F) to at least 38 °C (100.4 °F) during or within 4 hours of transfusion. Associated: chills, rigors, headache, malaise. Hemodynamic stability: blood pressure and breathing stay completely stable. |
Diagnosis of exclusion — all laboratory workup is completely normal: the direct antiglobulin test is negative; free plasma and urine hemoglobin are negative; haptoglobin, LDH (lactate dehydrogenase) and bilirubin stay normal; the blood bag Gram stain and culture are negative. Rule out sepsis: if the fever is 2 °C or more, the patient is hypotensive, or the product was platelets, work up for bacterial sepsis. Treatment: antipyretics (acetaminophen); meperidine for severe shaking rigors. Prevention: pre-storage leukoreduction dramatically reduces rates. Routine premedication is discouraged. |
21.17 · Objective e.iv — Allergic transfusion reaction: the one reaction with a restart rule
| Pathophysiology and features | The exclusive restart protocol |
|---|---|
| Mechanism: type I hypersensitivity mediated by preformed recipient IgE against soluble donor plasma proteins (localized mast cell activation). Frequency: common (1–3% of transfusions); most frequent with plasma-rich products (fresh frozen plasma, platelets). Presentation: pruritus, localized urticaria (hives), erythema, flushing. Strict negative criteria: NO fever or chills; NO respiratory distress or wheezing; NO hypotension or tachycardia. Laboratory evaluation: normal. Direct antiglobulin test negative; no hemolysis markers. |
1. Pause the infusion temporarily while evaluating. 2. Give an H1-blocker antihistamine (diphenhydramine 25–50 mg intravenous or oral). 3. Re-evaluate at 20–30 minutes: verify the complete absence of systemic or cardiopulmonary signs. 4. The only unit that can be restarted: if symptoms are strictly confined to the skin and completely resolve, the SAME unit may be restarted at a slower rate within the 4-hour hang time limit. 5. Critical red flag: if fever, dyspnea, wheezing or hypotension occur, DO NOT RESTART; escalate to the full reaction protocol. |
The restart rule in one line: the allergic reaction is the only transfusion reaction in which the unit can be restarted — when the symptoms are confined to the skin and fully resolve after the pause and the antihistamine, the same unit may be restarted at a slower rate within the 4-hour hang time; with fever, dyspnea, wheezing or hypotension it is never restarted.
21.18 · Objective e.v — Anaphylactic transfusion reaction: anti-IgA and epinephrine
| Pathophysiology and severe symptoms | Diagnostics and emergency protocol |
|---|---|
| Classic cause: a patient with severe congenital IgA deficiency (<0.05 mg/dL) who has formed circulating anti-IgA antibodies. Trigger: infusion of donor plasma containing normal IgA. Timing: sudden, within seconds to minutes after only 1 to 5 mL of product. Presentation (NO FEVER): laryngeal edema, stridor, bronchospasm, dyspnea; rapid circulatory collapse, severe hypotension, shock; angioedema, generalized flushing, nausea and vomiting. Key contrast: absence of fever distinguishes anaphylaxis from septic shock and acute hemolytic reactions. |
First-line: intramuscular epinephrine into the anterolateral thigh (adult 0.3 to 0.5 mg of 1 mg/mL; pediatric 0.01 mg/kg, maximum 0.5 mg). Never delay epinephrine for antihistamines or steroids. Supportive care: high-flow oxygen, airway protection, aggressive intravenous crystalloid boluses. Diagnostic testing: serum tryptase (drawn within 1–3 hours); quantitative IgA level and anti-IgA antibody titers. Future transfusions: must be washed red cells (strips plasma IgA) or products from verified IgA-deficient donors. |
Anaphylaxis by its timing. Anaphylaxis comes on suddenly, within seconds to minutes, after only 1 to 5 mL of product; the classic cause is anti-IgA in a severely IgA-deficient patient.
21.19 · Objective e — The five reactions side by side
| Reaction | Onset | Fever | Hypotension | Direct antiglobulin test | Hemolysis labs | Distinguishing finding |
|---|---|---|---|---|---|---|
| Acute hemolytic | Minutes to 24 h | Yes | Yes (shock) | Positive (new)* | Marked (pink plasma, red urine, low haptoglobin, high LDH) | ABO mismatch on recheck; acute disseminated intravascular coagulation |
| Delayed hemolytic | 3 to 30 days | Mild / variable | Rare | Positive (new) | Extravascular (spherocytes, high indirect bilirubin, drop in hemoglobin) | New alloantibody on the screen (Kidd, Rh) |
| Febrile non-hemolytic | During to 4 h | Yes (≥1 °C) | No | Negative | Normal (clear plasma and urine) | Diagnosis of exclusion; normal labs |
| Allergic | During to 4 h | No | No | Negative | Normal | Pruritus / urticaria; responds to an H1-blocker |
| Anaphylaxis | Seconds to minutes | No | Yes (shock) | Negative | Normal | Stridor / wheezing; high tryptase; anti-IgA |
*The slide marks the acute hemolytic direct antiglobulin test with an asterisk and gives no footnote; its own reaction slide explains it: the test may be negative if all donor cells are instantly lysed (21.14).
Cardinal rule 4 — the direct antiglobulin test separates hemolytic from non-hemolytic. It detects antibodies bound to red cells in vivo; a newly positive direct antiglobulin test is the hallmark of immune hemolysis. Cardinal rule 5 — the universal emergency protocol: for ANY suspected reaction, stop the blood, keep intravenous access open with saline, check vital signs, do the clerical check, notify the blood bank, and give intramuscular epinephrine for anaphylaxis.